cl-20221231
00000216652022FYfalsehttp://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2022#OtherOperatingIncomeExpenseNethttp://fasb.org/us-gaap/2022#NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#CostOfRevenuehttp://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpensehttp://www.colgate.com/20221231#InterestExpenseNethttp://fasb.org/us-gaap/2022#CostOfRevenuehttp://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpensehttp://www.colgate.com/20221231#InterestExpenseNetP3Yhttp://fasb.org/us-gaap/2022#OperatingIncomeLosshttp://fasb.org/us-gaap/2022#OperatingIncomeLoss67http://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent00000216652022-01-012022-12-310000021665us-gaap:CommonStockMember2022-01-012022-12-310000021665cl:A0.500NotesDue2026Member2022-01-012022-12-310000021665cl:A0300NotesDue2029Member2022-01-012022-12-310000021665cl:A1.375NotesDue2034Member2022-01-012022-12-310000021665cl:A0.875Notesdue2039Member2022-01-012022-12-3100000216652022-06-30iso4217:USD00000216652023-01-31xbrli:shares00000216652021-01-012021-12-3100000216652020-01-012020-12-31iso4217:USDxbrli:shares00000216652022-12-3100000216652021-12-310000021665us-gaap:CommonStockMember2019-12-310000021665us-gaap:AdditionalPaidInCapitalMember2019-12-310000021665cl:UnearnedCompensationMember2019-12-310000021665us-gaap:TreasuryStockMember2019-12-310000021665us-gaap:RetainedEarningsMember2019-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000021665us-gaap:NoncontrollingInterestMember2019-12-310000021665us-gaap:RetainedEarningsMember2020-01-012020-12-310000021665us-gaap:NoncontrollingInterestMember2020-01-012020-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310000021665us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310000021665us-gaap:TreasuryStockMember2020-01-012020-12-310000021665cl:UnearnedCompensationMember2020-01-012020-12-310000021665us-gaap:CommonStockMember2020-12-310000021665us-gaap:AdditionalPaidInCapitalMember2020-12-310000021665cl:UnearnedCompensationMember2020-12-310000021665us-gaap:TreasuryStockMember2020-12-310000021665us-gaap:RetainedEarningsMember2020-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000021665us-gaap:NoncontrollingInterestMember2020-12-310000021665us-gaap:RetainedEarningsMember2021-01-012021-12-310000021665us-gaap:NoncontrollingInterestMember2021-01-012021-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310000021665us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310000021665us-gaap:TreasuryStockMember2021-01-012021-12-310000021665us-gaap:CommonStockMember2021-12-310000021665us-gaap:AdditionalPaidInCapitalMember2021-12-310000021665cl:UnearnedCompensationMember2021-12-310000021665us-gaap:TreasuryStockMember2021-12-310000021665us-gaap:RetainedEarningsMember2021-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000021665us-gaap:NoncontrollingInterestMember2021-12-310000021665us-gaap:RetainedEarningsMember2022-01-012022-12-310000021665us-gaap:NoncontrollingInterestMember2022-01-012022-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310000021665us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310000021665us-gaap:TreasuryStockMember2022-01-012022-12-310000021665us-gaap:CommonStockMember2022-12-310000021665us-gaap:AdditionalPaidInCapitalMember2022-12-310000021665cl:UnearnedCompensationMember2022-12-310000021665us-gaap:TreasuryStockMember2022-12-310000021665us-gaap:RetainedEarningsMember2022-12-310000021665us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000021665us-gaap:NoncontrollingInterestMember2022-12-3100000216652022-01-012022-03-31cl:Dividend00000216652021-01-012021-03-3100000216652020-01-012020-03-3100000216652020-12-3100000216652019-12-31cl:business_segment0000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembercl:OralCareMember2022-01-012022-12-31xbrli:pure0000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembercl:OralCareMember2021-01-012021-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembercl:OralCareMember2020-01-012020-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembercl:PersonalCareMember2022-01-012022-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembercl:PersonalCareMember2021-01-012021-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembercl:PersonalCareMember2020-01-012020-12-310000021665cl:HomeCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-012022-12-310000021665cl:HomeCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-12-310000021665cl:HomeCareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-12-310000021665us-gaap:SalesRevenueNetMembercl:PetNutritionMemberus-gaap:ProductConcentrationRiskMember2022-01-012022-12-310000021665us-gaap:SalesRevenueNetMembercl:PetNutritionMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-12-310000021665us-gaap:SalesRevenueNetMembercl:PetNutritionMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2022-01-012022-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-12-310000021665us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-12-310000021665us-gaap:ShippingAndHandlingMember2022-01-012022-12-310000021665us-gaap:ShippingAndHandlingMember2021-01-012021-12-310000021665us-gaap:ShippingAndHandlingMember2020-01-012020-12-310000021665srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2022-01-012022-12-310000021665srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2022-01-012022-12-310000021665us-gaap:BuildingMembersrt:MaximumMember2022-01-012022-12-310000021665cl:LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMembersrt:MinimumMember2022-01-012022-12-310000021665cl:LocalBrandsTrademarksCustomerRelationshipsAndNonCompeteAgreementsMembersrt:MaximumMember2022-01-012022-12-310000021665cl:RedCollarMember2022-09-302022-09-30cl:plant0000021665cl:RedCollarMember2022-10-012022-12-310000021665cl:RedCollarMember2022-01-012022-12-310000021665cl:RedCollarMember2022-09-300000021665cl:PetNutritionMembercl:RedCollarMember2022-12-310000021665cl:GlobalProductivityInitiativeMembersrt:MinimumMember2022-01-270000021665cl:GlobalProductivityInitiativeMembersrt:MaximumMember2022-01-270000021665cl:GlobalProductivityInitiativeMembersrt:MinimumMember2022-12-310000021665cl:GlobalProductivityInitiativeMembersrt:MaximumMember2022-12-310000021665cl:GlobalProductivityInitiativeMemberus-gaap:OneTimeTerminationBenefitsMember2022-01-270000021665cl:GlobalProductivityInitiativeMembercl:AssetRelatedCostsMember2022-01-270000021665us-gaap:OtherRestructuringMembercl:GlobalProductivityInitiativeMember2022-01-270000021665cl:GlobalProductivityInitiativeMembersrt:NorthAmericaMember2022-01-272022-01-270000021665cl:GlobalProductivityInitiativeMembersrt:LatinAmericaMember2022-01-272022-01-270000021665srt:EuropeMembercl:GlobalProductivityInitiativeMember2022-01-272022-01-270000021665cl:GlobalProductivityInitiativeMembersrt:AsiaPacificMember2022-01-272022-01-270000021665cl:GlobalProductivityInitiativeMembercl:AfricaEurasiaMember2022-01-272022-01-270000021665cl:GlobalProductivityInitiativeMembercl:PetNutritionMember2022-01-272022-01-270000021665cl:GlobalProductivityInitiativeMemberus-gaap:CorporateMember2022-01-272022-01-270000021665cl:GlobalProductivityInitiativeMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembercl:OtherIncomeExpenseNetMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembercl:NonServiceRelatedPostretirementCostsMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembersrt:NorthAmericaMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembersrt:LatinAmericaMember2022-01-012022-12-310000021665srt:EuropeMembercl:GlobalProductivityInitiativeMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembersrt:AsiaPacificMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembercl:AfricaEurasiaMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembercl:PetNutritionMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMemberus-gaap:CorporateMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMemberus-gaap:OneTimeTerminationBenefitsMember2021-12-310000021665cl:IncrementalDepreciationMembercl:GlobalProductivityInitiativeMember2021-12-310000021665cl:GlobalProductivityInitiativeMembercl:AssetImpairmentMember2021-12-310000021665us-gaap:OtherRestructuringMembercl:GlobalProductivityInitiativeMember2021-12-310000021665cl:GlobalProductivityInitiativeMember2021-12-310000021665cl:GlobalProductivityInitiativeMemberus-gaap:OneTimeTerminationBenefitsMember2022-01-012022-12-310000021665cl:IncrementalDepreciationMembercl:GlobalProductivityInitiativeMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMembercl:AssetImpairmentMember2022-01-012022-12-310000021665us-gaap:OtherRestructuringMembercl:GlobalProductivityInitiativeMember2022-01-012022-12-310000021665cl:GlobalProductivityInitiativeMemberus-gaap:OneTimeTerminationBenefitsMember2022-12-310000021665cl:IncrementalDepreciationMembercl:GlobalProductivityInitiativeMember2022-12-310000021665cl:GlobalProductivityInitiativeMembercl:AssetImpairmentMember2022-12-310000021665us-gaap:OtherRestructuringMembercl:GlobalProductivityInitiativeMember2022-12-310000021665cl:GlobalProductivityInitiativeMember2022-12-310000021665srt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665srt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2021-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2021-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2021-12-310000021665srt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665srt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2021-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2020-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2021-01-012021-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2021-12-310000021665cl:OralPersonalAndHomeCareMember2020-12-310000021665cl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665cl:OralPersonalAndHomeCareMember2021-12-310000021665cl:PetNutritionMember2020-12-310000021665cl:PetNutritionMember2021-01-012021-12-310000021665cl:PetNutritionMember2021-12-310000021665srt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665srt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2022-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665srt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2022-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665srt:EuropeMembercl:OralPersonalAndHomeCareMember2022-12-310000021665srt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665srt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2022-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2022-01-012022-12-310000021665cl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2022-12-310000021665cl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665cl:OralPersonalAndHomeCareMember2022-12-310000021665cl:PetNutritionMember2022-01-012022-12-310000021665cl:PetNutritionMember2022-12-310000021665us-gaap:TrademarksMember2022-12-310000021665us-gaap:TrademarksMember2021-12-310000021665us-gaap:OtherIntangibleAssetsMember2022-12-310000021665us-gaap:OtherIntangibleAssetsMember2021-12-310000021665us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2022-12-310000021665us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2021-12-310000021665us-gaap:TrademarksMember2022-10-012022-12-310000021665us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember2022-10-012022-12-310000021665us-gaap:TrademarksMember2022-12-310000021665cl:FilorgaReportingUnitMember2022-10-012022-12-310000021665cl:FilorgaReportingUnitMember2022-12-3100000216652021-10-012021-12-310000021665cl:FilorgaReportingUnitMember2021-10-012021-12-310000021665cl:FilorgaReportingUnitMember2021-12-310000021665us-gaap:NotesPayableOtherPayablesMember2022-12-310000021665us-gaap:NotesPayableOtherPayablesMember2021-12-310000021665us-gaap:CommercialPaperMember2022-12-310000021665us-gaap:CommercialPaperMember2021-12-310000021665cl:FinanceLeaseObligationMember2022-12-310000021665cl:FinanceLeaseObligationMember2021-12-310000021665cl:ThreeYearNotesAt310PercentNumberMember2022-09-300000021665cl:ThreeYearNotesAt310PercentNumberMember2022-07-012022-09-300000021665cl:FiveYearNotesAt310PercentNumberMember2022-09-300000021665cl:FiveYearNotesAt310PercentNumberMember2022-07-012022-09-300000021665cl:TenYearNotesAt3250PercentNumberMember2022-09-300000021665cl:TenYearNotesAt3250PercentNumberMember2022-07-012022-09-300000021665cl:EightYearNotesAt030percentNumberMember2021-12-31iso4217:EUR0000021665cl:EightYearNotesAt030percentNumberMember2021-10-012021-12-310000021665cl:A000MediumTermNotesDue2021Member2021-12-310000021665cl:A1285GuaranteedNotesDue2030Member1990-12-31iso4217:CAD0000021665cl:A1285GuaranteedNotesDue2030Member2021-07-012021-09-300000021665us-gaap:RevolvingCreditFacilityMember2022-12-310000021665cl:AmendedDomesticRevolvingCreditFacility1500MillionCapacityMember2022-11-300000021665cl:AmendedDomesticRevolvingCreditFacility1500MillionCapacityMember2022-11-012022-11-30cl:country_and_territory0000021665us-gaap:InterestRateContractMember2022-12-310000021665us-gaap:InterestRateContractMember2021-12-310000021665us-gaap:ForwardContractsMember2021-12-310000021665us-gaap:ForwardContractsMember2022-12-310000021665us-gaap:ForeignExchangeContractMember2022-12-310000021665us-gaap:ForeignExchangeContractMember2021-12-310000021665us-gaap:CommodityContractMember2021-12-310000021665us-gaap:CommodityContractMember2022-12-310000021665us-gaap:OtherCurrentAssetsMember2022-12-310000021665us-gaap:OtherCurrentAssetsMember2021-12-310000021665us-gaap:FairValueInputsLevel2Member2022-12-310000021665us-gaap:FairValueInputsLevel2Member2021-12-310000021665us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000021665us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000021665us-gaap:LongTermDebtMember2022-12-310000021665us-gaap:LongTermDebtMember2021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2022-12-310000021665us-gaap:DebtMemberus-gaap:FairValueHedgingMember2022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForwardContractsMember2022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CommodityContractMember2022-12-310000021665us-gaap:FairValueHedgingMember2022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-12-310000021665us-gaap:DebtMemberus-gaap:CashFlowHedgingMember2022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2022-12-310000021665us-gaap:CashFlowHedgingMember2022-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2022-12-310000021665us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2022-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2022-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:ForwardContractsMember2022-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:CommodityContractMember2022-12-310000021665us-gaap:NetInvestmentHedgingMember2022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2021-12-310000021665us-gaap:DebtMemberus-gaap:FairValueHedgingMember2021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:InterestRateContractMember2021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:ForwardContractsMember2021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CommodityContractMember2021-12-310000021665us-gaap:FairValueHedgingMember2021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-12-310000021665us-gaap:DebtMemberus-gaap:CashFlowHedgingMember2021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:InterestRateContractMember2021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2021-12-310000021665us-gaap:CashFlowHedgingMember2021-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-12-310000021665us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2021-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:ForwardContractsMember2021-12-310000021665us-gaap:NetInvestmentHedgingMemberus-gaap:CommodityContractMember2021-12-310000021665us-gaap:NetInvestmentHedgingMember2021-12-310000021665us-gaap:CostOfSalesMember2022-01-012022-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310000021665cl:InterestIncomeExpenseNetMember2022-01-012022-12-310000021665us-gaap:CostOfSalesMember2021-01-012021-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310000021665cl:InterestIncomeExpenseNetMember2021-01-012021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMemberus-gaap:InterestRateContractMember2022-01-012022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:InterestRateContractMember2022-01-012022-12-310000021665us-gaap:FairValueHedgingMembercl:InterestIncomeExpenseNetMemberus-gaap:InterestRateContractMember2022-01-012022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMemberus-gaap:InterestRateContractMember2021-01-012021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:InterestRateContractMember2021-01-012021-12-310000021665us-gaap:FairValueHedgingMembercl:InterestIncomeExpenseNetMemberus-gaap:InterestRateContractMember2021-01-012021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665us-gaap:FairValueHedgingMembercl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665us-gaap:FairValueHedgingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665us-gaap:FairValueHedgingMembercl:InterestIncomeExpenseNetMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2022-01-012022-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2022-01-012022-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2022-01-012022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2021-01-012021-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2021-01-012021-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:CashFlowHedgingMemberus-gaap:CommodityContractMember2021-01-012021-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForwardContractsMember2022-01-012022-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2022-01-012022-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2022-01-012022-12-310000021665us-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMemberus-gaap:ForwardContractsMember2021-01-012021-12-310000021665us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2021-01-012021-12-310000021665cl:InterestIncomeExpenseNetMemberus-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2021-01-012021-12-310000021665us-gaap:ForeignExchangeContractMember2022-01-012022-12-310000021665us-gaap:ForeignExchangeContractMember2021-01-012021-12-310000021665us-gaap:ForwardContractsMember2022-01-012022-12-310000021665us-gaap:ForwardContractsMember2021-01-012021-12-310000021665us-gaap:CommodityContractMember2022-01-012022-12-310000021665us-gaap:CommodityContractMember2021-01-012021-12-310000021665us-gaap:DebtMember2022-01-012022-12-310000021665us-gaap:DebtMember2021-01-012021-12-310000021665cl:Program2022Member2022-03-100000021665cl:Program2022Member2022-01-012022-12-31cl:plan0000021665cl:PerformanceBasedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2022-01-012022-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMember2021-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMember2022-01-012022-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMember2022-12-310000021665cl:PerformanceBasedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2022-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2022-01-012022-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2022-12-310000021665cl:TimeVestedRestrictedStockUnitsMember2021-12-310000021665cl:TimeVestedRestrictedStockUnitsMember2022-01-012022-12-310000021665cl:TimeVestedRestrictedStockUnitsMember2022-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2021-01-012021-12-310000021665cl:TimeVestedRestrictedStockUnitsMembercl:IncentiveStockPlansMember2020-01-012020-12-310000021665cl:StockOptionPlansMember2022-01-012022-12-310000021665cl:StockOptionPlansMember2018-01-012018-12-310000021665cl:StockOptionPlansMember2022-12-310000021665cl:StockOptionPlansMember2021-01-012021-12-310000021665cl:StockOptionPlansMember2020-01-012020-12-310000021665country:US2022-07-012022-09-300000021665us-gaap:DefinedBenefitPlanEquitySecuritiesMembercountry:US2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:DefinedBenefitPlanEquitySecuritiesMember2022-12-310000021665country:USus-gaap:FixedIncomeSecuritiesMember2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:FixedIncomeSecuritiesMember2022-12-310000021665country:UScl:RealEstateandOtherInvestmentsMember2022-12-310000021665us-gaap:ForeignPlanMembercl:RealEstateandOtherInvestmentsMember2022-12-310000021665country:US2022-12-310000021665us-gaap:ForeignPlanMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanUSCommonStocksMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanUSCommonStocksMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanInternationalCommonStockMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanInternationalCommonStockMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanPooledFundsMembercountry:US2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanPooledFundsMember2022-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanFixedIncomeSecuritiesMember2022-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeSecuritiesMember2022-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2022-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2022-12-310000021665us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2022-12-310000021665us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310000021665cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000021665cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanFixedIncomeFundsMember2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanFixedIncomeFundsMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanHedgeFundsMember2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanHedgeFundsMember2022-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:DefinedBenefitPlanRealEstateMember2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:DefinedBenefitPlanRealEstateMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:UScl:OtherAssetsandLiabilitiesNetMember2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanUSCommonStocksMember2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanUSCommonStocksMember2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanInternationalCommonStockMember2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanInternationalCommonStockMember2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanPooledFundsMembercountry:US2021-12-310000021665us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanPooledFundsMember2021-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanFixedIncomeSecuritiesMember2021-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanFixedIncomeSecuritiesMember2021-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembercountry:UScl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2021-12-310000021665us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:DefinedBenefitPlanGuaranteedInvestmentContractsMember2021-12-310000021665us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2021-12-310000021665us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000021665cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021665cl:DefinedBenefitPlanDomesticDevelopedandEmergingMarketsEquityFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanFixedIncomeFundsMember2021-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanFixedIncomeFundsMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanHedgeFundsMember2021-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembercl:DefinedBenefitPlanHedgeFundsMember2021-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021665cl:DefinedBenefitPlanMultiAssetFundsMemberus-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:DefinedBenefitPlanRealEstateMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:USus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:UScl:OtherAssetsandLiabilitiesNetMember2021-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMembercl:OtherAssetsandLiabilitiesNetMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2021-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000021665srt:MinimumMember2022-01-012022-12-310000021665srt:MaximumMember2022-01-012022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2021-01-012021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2022-01-012022-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMember2022-12-310000021665us-gaap:PensionPlansDefinedBenefitMember2021-12-310000021665us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-12-310000021665us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310000021665us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310000021665us-gaap:EmployeeStockOptionMember2022-01-012022-12-310000021665us-gaap:EmployeeStockOptionMember2021-01-012021-12-310000021665us-gaap:EmployeeStockOptionMember2020-01-012020-12-310000021665us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310000021665us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310000021665us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310000021665srt:MinimumMember2022-12-310000021665srt:MaximumMember2022-12-31cl:case00000216652005-12-3100000216652017-07-3100000216652019-04-012019-04-3000000216652022-10-012022-12-310000021665us-gaap:SalesRevenueNetMember2022-12-310000021665us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercl:WalmartIncMember2022-01-012022-12-310000021665us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercl:WalmartIncMember2021-01-012021-12-310000021665us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembercl:WalmartIncMember2020-01-012020-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2022-01-012022-12-310000021665us-gaap:OperatingIncomeLossMemberus-gaap:CorporateNonSegmentMember2022-01-012022-12-310000021665srt:AsiaPacificMember2022-01-012022-12-310000021665cl:GlobalGrowthandEfficiencyProgramMember2020-01-012020-12-310000021665us-gaap:OperatingIncomeLossMemberus-gaap:CorporateNonSegmentMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2022-01-012022-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2021-01-012021-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2022-01-012022-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2021-01-012021-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2020-01-012020-12-310000021665country:UScl:OralPersonalAndHomeCareMember2022-01-012022-12-310000021665country:UScl:OralPersonalAndHomeCareMember2021-01-012021-12-310000021665country:UScl:OralPersonalAndHomeCareMember2020-01-012020-12-310000021665country:UScl:PetNutritionMember2022-01-012022-12-310000021665country:UScl:PetNutritionMember2021-01-012021-12-310000021665country:UScl:PetNutritionMember2020-01-012020-12-310000021665us-gaap:CorporateNonSegmentMember2022-01-012022-12-310000021665us-gaap:CorporateNonSegmentMember2021-01-012021-12-310000021665us-gaap:CorporateNonSegmentMember2020-01-012020-12-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2022-12-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2021-12-310000021665us-gaap:OperatingSegmentsMembersrt:NorthAmericaMembercl:OralPersonalAndHomeCareMember2020-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2022-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2021-12-310000021665us-gaap:OperatingSegmentsMembersrt:LatinAmericaMembercl:OralPersonalAndHomeCareMember2020-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2022-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2021-12-310000021665srt:EuropeMemberus-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-12-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2022-12-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2021-12-310000021665us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembercl:OralPersonalAndHomeCareMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2022-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2021-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMembercl:AfricaEurasiaMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2022-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2021-12-310000021665us-gaap:OperatingSegmentsMembercl:OralPersonalAndHomeCareMember2020-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2022-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2021-12-310000021665us-gaap:OperatingSegmentsMembercl:PetNutritionMember2020-12-310000021665us-gaap:CorporateNonSegmentMember2022-12-310000021665us-gaap:CorporateNonSegmentMember2021-12-310000021665us-gaap:CorporateNonSegmentMember2020-12-310000021665country:US2022-12-310000021665country:US2021-12-310000021665country:US2020-12-310000021665us-gaap:NonUsMember2022-12-310000021665us-gaap:NonUsMember2021-12-310000021665us-gaap:NonUsMember2020-12-31cl:leaseRenewalOption0000021665cl:GlobalGrowthandEfficiencyProgramMember2021-01-012021-12-310000021665cl:A2022GlobalProductivityInitiativeMember2022-01-012022-12-310000021665cl:A2022GlobalProductivityInitiativeMember2021-01-012021-12-310000021665cl:A2022GlobalProductivityInitiativeMember2020-01-012020-12-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310000021665us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310000021665us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310000021665us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2021-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2022-01-012022-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2022-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-012022-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2020-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2021-01-012021-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-012021-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2019-12-310000021665cl:AllowanceForDoubtfulAccountsAndEstimatedReturnsMember2020-01-012020-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310000021665us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                                  to                          .
Commission File Number 1-644
https://cdn.kscope.io/c34b46c8d666c793ca36e59f0b6b5f78-cl-20221231_g1.jpg
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
Delaware13-1815595
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
300 Park Avenue
New York, New York10022
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code 212-310-2000
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par valueCLNew York Stock Exchange
0.500% Notes due 2026CL26New York Stock Exchange
0.300% Notes due 2029CL29New York Stock Exchange
1.375% Notes due 2034CL34New York Stock Exchange
0.875% Notes due 2039CL39New York Stock Exchange
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes No
If securities are registered pursuant to Section 12(b) of the Exchange Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The aggregate market value of Colgate-Palmolive Company Common Stock held by non-affiliates as of June 30, 2022 (the last business day of its most recently completed second quarter) was approximately $66.8 billion.
There were 830,378,790 shares of Colgate-Palmolive Company Common Stock outstanding as of January 31, 2023.
DOCUMENTS INCORPORATED BY REFERENCE:
DocumentsForm 10-K Reference
Portions of Proxy Statement for the 2023 Annual Meeting of StockholdersPart III, Items 10 through 14




Colgate-Palmolive Company
Table of Contents
Part I  Page
     
Item 1.Business
Item 1A.  Risk Factors
Item 1B.Unresolved Staff Comments
Item 2.Properties
Item 3.Legal Proceedings
Item 4.Mine Safety Disclosures
    
Part II   
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6.[Reserved]
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7A.Quantitative and Qualitative Disclosures About Market Risk
Item 8.Financial Statements and Supplementary Data
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A.Controls and Procedures
Item 9B.Other Information
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Part III   
Item 10.Directors, Executive Officers and Corporate Governance
Item 11.Executive Compensation
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13.Certain Relationships and Related Transactions and Director Independence
Item 14.Principal Accountant Fees and Services
Part IV   
Item 15.Exhibits and Financial Statement Schedules
Item 16.Form 10-K Summary
     
Signatures





PART I

ITEM 1.    BUSINESS

(a) General Development of the Business

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate”) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth through science-led, core and premium innovation and superior shareholder returns, as well as provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling products globally that make people’s and their pets’ lives healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion (“DE&I”) strategies across our organization. Our products are marketed in over 200 countries and territories throughout the world. Colgate was founded in 1806 and incorporated under the laws of the State of Delaware in 1923.

For recent business developments and other information, refer to the information set forth under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Executive Overview,” “– Outlook,” “–Results of Operations” and “– Liquidity and Capital Resources” in Part II, Item 7 of this report.

(c) Narrative Description of the Business

We operate in two product segments: Oral, Personal and Home Care; and Pet Nutrition. We are a leader in Oral Care with global leadership in the toothpaste and manual toothbrush categories according to market share data. We sell our toothpastes under brands such as Colgate, Darlie, elmex, hello, meridol, Sorriso and Tom’s of Maine, our toothbrushes under brands such as Colgate, Darlie, elmex and meridol and our mouthwashes under brands such as Colgate, elmex and meridol. Our Oral Care business also includes pharmaceutical products for dentists and other oral health professionals.

We are a leader in many product categories of the Personal Care market with global leadership in liquid hand soap, according to market share data, which we sell under brands such as Palmolive, Protex and Softsoap. Our Personal Care products also include Irish Spring, Palmolive and Protex bar soaps, Irish Spring, Palmolive, Sanex and Softsoap shower gels, Lady Speed Stick, Sanex, Speed Stick and Tom’s of Maine deodorants and antiperspirants, EltaMD, Filorga and PCA SKIN skin health products and Palmolive shampoos and conditioners.

We manufacture and market a wide array of products for the Home Care market, including Ajax, Axion and Palmolive dishwashing liquids and Ajax, Fabuloso and Murphy household cleaners. We are a market leader in fabric conditioners with leading brands, including Suavitel in Latin America, Soupline in Europe, and Cuddly in the South Pacific, according to market share data.

Sales of Oral, Personal and Home Care products accounted for 43%, 19% and 17%, respectively, of our total worldwide Net sales in 2022. Geographically, Oral Care is a significant part of our business in Asia Pacific, comprising approximately 82% of Net sales in that region for 2022.

Through our Hill’s Pet Nutrition segment (“Hill’s” or “Pet Nutrition”), we are a world leader in specialty pet nutrition products for dogs and cats with products marketed in over 80 countries and territories worldwide. Hill’s markets pet foods primarily under two brands. Hill’s Science Diet, which is called Hill’s Science Plan in Europe, is a range of products for everyday nutritional needs. Hill’s Prescription Diet is a range of therapeutic pet foods to help nutritionally support dogs and cats in various different stages of health. Sales of Pet Nutrition products accounted for 21% of our total worldwide Net sales in 2022.

For more information regarding our worldwide Net sales by product category, refer to Note 1, Nature of Operations and Note 14, Segment Information to the Consolidated Financial Statements.

For additional information regarding market share data, see Market Share Information in Part II, Item 7 of this report.

1


Distribution; Raw Materials; Competition; Trademarks and Patents

Our Oral, Personal and Home Care products are sold to a variety of traditional and eCommerce retailers, wholesalers and distributors worldwide. Pet Nutrition products are sold by authorized pet supply retailers, veterinarians and eCommerce retailers. Certain of our products are also sold direct-to-consumer. Our sales to Walmart, Inc. and its affiliates represent approximately 11% of our Net sales in 2022. No other customer represents more than 10% of our Net sales. We support our products with advertising, promotion and other marketing (with increasing emphasis on digital) to build awareness and trial of our products. Our products are marketed by a direct sales force at individual operating subsidiaries or business units and by distributors or brokers.

The majority of raw and packaging materials used in our products are purchased from other companies and are available from several sources. No single raw or packaging material represents, and no single supplier provides, a significant portion of our total material requirements. We do, however, purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers. For certain materials, new suppliers may have to be qualified under industry, governmental and/or Colgate standards, which can require additional investment and take a significant period of time. Raw and packaging material commodities, such as essential oils, resins, tropical oils, pulp, tallow, corn, poultry and soybeans, are subject to market price variations. For further information regarding the impact of changes in commodity prices, see Item 1A, “Risk Factors - Volatility in material and other costs could adversely impact our profitability” and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Our products are sold in a highly competitive global marketplace which has experienced increased retail trade concentration, the substantial growth of eCommerce, the integration of traditional and digital operations at key retailers and the growing presence of large-format retailers, discounters and eCommerce retailers. Products similar to those that we produce and sell are available from multinational and local competitors in the U.S. and around the world. Certain of our competitors are larger and have greater resources than we do. In addition, the substantial growth in eCommerce has encouraged the entry of new competitors and business models. In certain geographies, we also face strong local competitors, who may be more agile and have better local consumer insights than we do. Private label brands sold by retailers are also a source of competition for certain of our products.

The retail landscape in many of our markets continues to evolve as a result of the continued growth of eCommerce, changing consumer behavior and preferences (as consumers increasingly shop online and via mobile and social applications) and the increased presence of alternative retail channels, such as subscription services and direct-to-consumer businesses. We face competition in several aspects of our business, including pricing, promotional activities, new products and brand introductions and expansion into new geographies and channels. Product quality, innovation, brand recognition, marketing capability and acceptance of new products and brands largely determine success in Colgate's operating segments.

We consider trademarks to be of material importance to our business. We follow a practice of seeking trademark protection in the U.S. and throughout the world where our products are sold. Principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. Our rights in these trademarks endure for as long as they are used and/or registered. Although we actively develop and maintain a portfolio of patents, no single patent is considered significant to the business as a whole.












2


COVID-19

The COVID-19 pandemic and government steps to reduce the spread and address the impact of COVID-19 have had and continue to have an impact on the way people live, work, interact and shop. During the COVID-19 pandemic, many of the communities in which we manufacture, market and sell our products experienced and may in the future experience “stay at home” orders, travel or movement restrictions and other government actions to address the pandemic. While the impact of COVID-19 on our business has largely abated at this time, uncertainties continue, particularly in China where we have substantial manufacturing facilities and business, and in the travel retail channel, where we have experienced and may continue to experience disruptions particularly in our Filorga business. We have also experienced certain disruptions to our global supply chain due to COVID-19, which have impacted and may continue to impact sales of and consumer access to our products. In addition, we have witnessed changes in the purchasing patterns of our customers, including a shift in many markets to purchasing our products online. COVID-19 may continue to impact consumers’ behavior, shopping patterns and consumption preferences.

While we currently expect to be able to continue operating our business as described above, uncertainty resulting from COVID-19 could result in unforeseen additional disruptions to our business, including our global supply chain and retailer network, and/or require us to incur additional operational costs.

For additional information regarding COVID-19’s impact on our business, see Part I, Item 1A “Risk Factors” and Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Executive Overview.”

Government Regulations

As a global company, we are subject to extensive governmental regulations, including environmental rules and regulations, in the U.S. and abroad. The most significant government regulations that impact our business are discussed below. It is our policy and practice to comply with all government regulations applicable to our business. In 2022, compliance with these regulations did not have, and we do not expect such compliance in the future to have, a material adverse effect on our capital expenditures, earnings or competitive position. For further discussion of how global legal and regulatory requirements may impact our business, see Part I, Item 1A, “Risk Factors.”

Product Development: Legal and regulatory requirements apply to most aspects of our products, including their development, ingredients, formulation, manufacture, packaging content, labeling, storage, transportation, distribution, export, import, advertising, sale and environmental impact. U.S. federal authorities, including the U.S. Food and Drug Administration, the Federal Trade Commission, the Consumer Product Safety Commission, the Occupational, Health and Safety Administration and the Environmental Protection Agency, regulate different aspects of our business, along with parallel authorities at the state and local levels and comparable authorities overseas.


Anti-Corruption, Anti-Bribery, Commercial Bribery and Competition: We are subject to anti-corruption laws and regulations, including the U.S. Foreign Corrupt Practices Act and other laws that generally prohibit the making or offering of improper payments to foreign government officials and political figures for the purpose of obtaining or retaining business or to gain an unfair business advantage, and laws that prohibit commercial bribery. In addition, our selling practices are regulated by competition law authorities in the U.S. and abroad.

Privacy and Data Protection: Our collection, storage, transfer and/or processing of customer, consumer, employee, vendor and other stakeholder information and personal data is subject to important data protection laws and regulations in the U.S. and abroad, including the General Data Protection Regulation.

Trade Compliance: We are subject to laws and sanctions imposed by the U.S., including, without limitation, those imposed by the U.S. Treasury Department’s Office of Foreign Asset Control (“OFAC”), and/or by other jurisdictions that may prohibit us or certain of our affiliates from doing business in certain countries or restrict the kind of business that may be conducted. For information regarding the impact of the war in Ukraine, refer to Part II, Item 7 “Management’s Discussions and Analysis of Financial Condition and Results of Operations - Executive Overview”



3


Human Capital Management

Human capital matters at Colgate are managed by our Global Human Resources function, led by our Chief Human Resources Officer, with oversight from the Personnel and Organization Committee of our Board of Directors (the “Board”). As of December 31, 2022, we had approximately 33,800 employees based in over 100 countries. Approximately two-thirds of our revenues are generated from markets outside the U.S. and 86% of our employees are located outside the U.S. Approximately 36% of our employees are based in Asia Pacific, 30% are based in Latin America, 15% are based in Europe, 14% are based in North America and 5% are based in Africa/Eurasia. Our global workforce covers a broad range of functions, from manufacturing employees to management personnel and certain of our employees are represented by unions or works councils.

Colgate’s Culture and Core Values

As we work to achieve Colgate’s purpose to reimagine a healthier future for all people, their pets and our planet, Colgate people, working around the world, share a commitment to our three core corporate values: Caring, Global Teamwork and Continuous Improvement. These values are reflected not only in the quality of our products and reputation, but also in our dedication to serving the communities where we live and work, as reflected in our sustainability and social impact and DE&I strategies. With these values, we work to maintain a strong culture based on integrity, ethical behavior and a commitment to doing the right thing. Underlying these values and our strong culture is the commitment of all Colgate people to maintain the highest ethical standards and demonstrate ethical leadership, including compliance with Colgate policies and our Code of Ethics.

CARING: We care about people - Colgate people, consumers, customers, stockholders, business partners and people in the communities where we live and work. We are committed to acting with compassion, integrity, honesty and high ethics in all situations and to providing our employees with an innovative and inclusive work environment.

GLOBAL TEAMWORK: All Colgate people are part of a global team, committed to working and collaborating together across functions and countries. Only by sharing ideas, technologies and talents can we achieve and sustain profitable growth.

CONTINUOUS IMPROVEMENT: We are committed to getting better every day in all that we do, as individuals and as teams. We continue to drive a learning culture and transform our learning strategy to better meet our evolving business needs. We provide our employees with learning experiences focused on building leadership skills and offer training programs that are closely aligned with our business strategy. Specifically, we continue to embed new ways of working and leadership principles to, among other things, instill a growth mindset to drive innovation with focus, empowerment, experimentation and digitalization. Colgate people are embracing data and analytics as part of their jobs, and we are scaling new capabilities worldwide. In 2022, approximately 14,000 Colgate people completed a new Data Literacy & Analytics Academy course we created with training experts. We are also committed to listening to our employees and seeing how the company is evolving and growing through regular employee engagement surveys.

Diversity, Equity & Inclusion

We believe our people are crucial to our ongoing business success and aim to recruit, develop and retain strong and diverse talent. We celebrate differences, promote an equitable and inclusive environment and value the contributions of all Colgate people. At Colgate, we are proud of our collaborative spirit – what we call The Power of WE. As a truly global company, we are working to ensure that our workforce reflects the diversity of the communities in which we live and work. As of December 31, 2022, our global workforce was approximately 59% male and 41% female. Women represented approximately 54% of our salaried and clerical employees, 44% of our people managers, 42% of Colgate’s executives and 36% of senior leadership. Measuring the race/ethnicity of our workforce is challenging to do on a global basis. In the U.S., on an employee self-reported basis, the racial/ethnic composition of our workforce was approximately 68% White, 12% Hispanic, 9% Asian, 9% Black, and 2% Other. The racial/ethnic composition of our people managers was approximately 61% White, 16% Hispanic, 14% Asian and 9% Black; the composition of our executives was approximately 58% White, 19% Hispanic, 15% Asian, 7% Black, and 1% Other; and the composition of senior leadership was approximately 61% White, 15% Hispanic, 12% Asian and 12% Black. “Other” refers to American Indian/Alaska Native, two or more races or Native Hawaiian/other Pacific Islander. In this section, “people managers” refers to employees with roles that have at least one direct report, “executives” refers to those employees who are eligible to participate in Colgate’s equity incentive compensation plans and “senior leadership” refers to employees who are Vice Presidents and above.
4


We are committed to providing all of our employees with an equitable and inclusive work environment, learning opportunities and promotion and growth opportunities. A vital piece of our DE&I strategy has been ensuring that our succession planning process incorporates the advancement of women and people of all cultures, including underrepresented communities. To help further foster inclusiveness, we support employee resource groups for team members of many different identities, interests and backgrounds, including underrepresented communities. Each of these resource groups contributes to our inclusive work environment by developing and implementing programs to promote business and community involvement as well as cultural awareness. We also partner with external organizations to develop an inclusive and supportive work environment.

Our global DE&I strategy aims to further advance our commitment to become an even more diverse, equitable and inclusive organization. The four pillars of our strategy are People, Community, Supplier Diversity and Communication. Consistent with this strategy, we are working to implement policies, learning experiences and processes that promote awareness, empathy, advocacy and opportunity; become an ally for positive change for the underserved in communities in which we live and work; support minority and women-owned suppliers to enable success of diversity-owned businesses; and promote dialogue around DE&I to increase awareness and advance the culture change to achieve our vision. In addition, we continued mandatory allyship and unconscious bias training for all salaried and clerical employees at Colgate that was first introduced in 2021 to help our employees better understand DE&I concepts and embed allyship as a daily practice. Our Board, through its Nominating, Governance and Corporate Responsibility Committee and Personnel and Organization Committee, receives regular updates from management on our DE&I efforts.

Succession Planning

We have a rigorous succession planning process, led by our Global Human Resources function. Our Board is also extensively involved in succession planning and people development with special focus on CEO succession. As part of the succession planning process, we review and discuss potential successors to key positions and examine backgrounds, capabilities and appropriate developmental assignments.

Compensation Philosophy

Given the importance of Colgate people to our business success, motivating and retaining critical talent is a key focus. We view compensation as an important tool to motivate leaders at all levels of the organization. For information regarding our compensation philosophy and executive compensation programs, please see our Proxy Statement to be filed with the United States Securities and Exchange Commission (the “SEC”) in connection with the 2023 Annual Meeting of Stockholders.


Sustainability

We view sustainability as being critically important to our overall business and growth strategy. Our 2025 Sustainability & Social Impact Strategy, which we announced in November 2020, is focused on three key ambitions - preserving our environment by accelerating action on climate change and reducing our environmental footprint; helping millions of homes by empowering people to develop healthier habits; and driving social impact with a commitment to helping to ensure the well-being of all people and their pets. These ambitions are supported by actionable targets consistent with our continued commitment to building environmental and social consciousness into our decision-making.

In 2022, we made progress on the targets set forth in our 2025 Sustainability & Social Impact Strategy.

Reduce Plastic Waste: As a positive step toward achieving our targets to reduce the use of new plastic by a third and make our packaging 100% recyclable, reusable or compostable by 2025, we are implementing our first-of-its-kind recyclable toothpaste tube across our toothpaste portfolio. Since introducing our first-of-its-kind recyclable toothpaste tube in 2019, as of December 31, 2022, we have transitioned over 70% of our toothpaste SKUs in North America to recyclable tubes. We continue to share the tube technology and, as of December 31, 2022, we have shared it with third parties by holding approximately 70 sessions to encourage recyclability of all tubes in practice and at scale. We are committed to the success of Colgate Keep, our first-of-its-kind manual toothbrush with a replaceable head and a reusable aluminum handle for 80% less plastic waste compared to similarly sized Colgate toothbrushes.

5


Accelerate Action on Climate Change: Colgate is taking steps to accelerate action on climate change through science-based near-term, long-term and Net Zero 2040 emissions targets across our operations and supply chain, which have been approved by The Science Based Targets initiative. To support our goal to become Net Zero carbon in our operations by 2040, we have built a global renewable energy master plan which includes roadmaps by division to cover our manufacturing facilities and owned warehouses, global technology centers and offices and have engaged our priority Tier 1 Suppliers in support of our goal to reduce their greenhouse gas emissions by 20% by 2025 (versus a 2020 baseline).

Lead with Zero Waste Facilities: It is our goal to achieve TRUE Zero Waste certifications at 100% of our operations, which we define as our manufacturing facilities, owned and operated warehouses, global technology centers and strategic offices, by 2025. In 2022, six more of our sites achieved TRUE certification. That brings the total number of TRUE certified sites, as of December 31, 2022, to 32 across five continents in 19 countries.

Ingredient Transparency: We continue to promote ingredient transparency and seek to follow the highest safety and efficacy standards as we formulate our products. We have rolled out a new “Fragrance & Flavors Share for Good” ingredient transparency program, which provides additional ingredient information.

Social Impact: Colgate Bright Smiles, Bright Futures is our flagship oral health education and well-being initiative. Since the program was established in 1991, we have reached over 1.6 billion children and their families in more than 80 countries. Through our Hill's Food, Shelter & Love program, we have helped over 13 million shelter pets find forever homes since 2002.

Additional information about our sustainability targets and efforts, including our 2021 Sustainability and Social Impact Report, our 2022 Climate Transition & Net Zero Action Plan and our reports aligned with the Task Force on Climate-related Financial Disclosures (TCFD) recommendations and Sustainability Accounting Standards Board (SASB) can be found in the Sustainability section of our website at https://www.colgatepalmolive.com/sustainability. References to these reports and our website are for informational purposes only and neither the reports nor the other information on our website is incorporated by reference into this Annual Report on Form 10-K.





























6


Information about our Executive Officers

The following is a list of our executive officers as of February 16, 2023:
NameAgeDate First Elected OfficerPresent Title
Noel R. Wallace582009Chairman of the Board, President and
Chief Executive Officer
Stanley J. Sutula III572020Chief Financial Officer
Jennifer M. Daniels592014Chief Legal Officer and Secretary
John W. Kooyman582019Chief of Staff
Prabha Parameswaran642019Group President, Growth and Strategy
Panagiotis Tsourapas582019Group President, Europe and Developing Markets
Sally Massey492020Chief Human Resources Officer
Gregory O. Malcolm552022Vice President and Controller

Each of our executive officers listed above has served the Company or our subsidiaries in various executive capacities for the past five years with the exception of Stanley J. Sutula III, Chief Financial Officer. Prior to joining the company, Mr. Sutula was Executive Vice President and Chief Financial Officer of Pitney Bowes Inc., which he joined in 2017.

Under our By-Laws, our officers hold office until their respective successors are chosen and qualified or until they have resigned, retired or been removed by the affirmative vote of a majority of our Board. There are no family relationships between any of our executive officers, and there is no arrangement or understanding between any executive officer and any other person pursuant to which the executive officer was elected.

(e) Available Information

Our website address is www.colgatepalmolive.com. The information contained on our website is not included as a part of, or incorporated by reference into, this Annual Report on Form 10-K. We make available, free of charge, on our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, interactive data files posted pursuant to Rule 405 of Regulation S-T, Current Reports on Form 8-K and amendments to such reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Also available on our website are the Company’s Code of Conduct and Board Guidelines on Significant Corporate Governance Issues, the charters of the Committees of the Board, Specialized Disclosure Reports on Form SD, reports under Section 16 of the Exchange Act of transactions in Company stock by directors and executive officers and our Proxy Statements.

7


ITEM 1A.    RISK FACTORS

In addition to the risks described elsewhere in this report, set forth below is a summary of the material risks to an investment in our securities. These risks, some of which have occurred and/or are occurring and any of which could occur in the future, are not the only ones we face. Additional risks not presently known to us or that we currently deem immaterial may also have an adverse effect on us. If any of these risks actually occur, our business, results of operations, cash flows and financial condition could be materially and adversely impacted, which might cause the value of our securities to decline.

Business and Industry Risks

We face risks associated with significant international operations, including exposure to foreign currency fluctuations.

We operate on a global basis serving consumers in more than 200 countries and territories with approximately two-thirds of our Net sales originating in markets outside the U.S. While geographic diversity helps to reduce our exposure to risks in any one country or part of the world, it also means that we face risks associated with significant international operations, including, but not limited to:

changing macroeconomic conditions in our markets, including as a result of inflation, the war in Ukraine, volatile commodity prices and increases in the cost of raw and packaging materials, labor, energy and logistics;

political or economic instability, geopolitical events, wars and military conflicts, such as the war in Ukraine, environmental events, widespread health emergencies, such as COVID-19 or other pandemics or epidemics, natural disasters or social or labor unrest;

changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues, profits and cash flows from non-U.S. markets or increase our supply costs, as measured in U.S. dollars, in those markets;

exchange controls and other limits on our ability to import or export raw materials or finished product, including as a result of COVID-19, and the war in Ukraine, or to repatriate earnings from overseas;

lack of well-established, reliable and/or impartial legal systems in certain countries where we operate and difficulties in enforcing contractual, intellectual property or other legal rights;

foreign ownership and investment restrictions and the potential for nationalization or expropriation of property or other resources; and

changes to trade policies and agreements and other foreign or domestic legal and regulatory requirements, including those resulting in potentially adverse tax consequences or the imposition of and/or the increase in trade restrictions and/or tariffs, sanctions, price controls, labor laws, travel or immigration restrictions (including as a result of pandemics, epidemics or other widespread health emergencies, such as the COVID-19 pandemic), profit controls or other government controls, including as a result of the war in Ukraine.

Any or all of the foregoing risks could have a significant impact on our ability to sell our products on a competitive basis in international markets and may adversely affect our business, results of operations, cash flows and financial condition. In addition, a number of these risks may adversely impact consumer confidence and consumption, which could reduce sales volumes of our products or result in a shift in our product mix from higher margin to lower margin product offerings.

We face risks resulting from political and macroeconomic instability and geopolitical events, such as the ongoing war in Ukraine and the related geopolitical tensions. We suspended the importation and sales of all products in Russia other than essential health and hygiene products for everyday use and ceased all capital investments and media activities in Russia. While these actions have impacted our Eurasia business, they have not had a material impact on our business, results of operations, cash flow or financial condition. In 2022, our Eurasia business constituted approximately 2% of our consolidated net sales and approximately 3% of our consolidated operating profit (the majority of which was Russia). We,
8


however, have experienced, and expect to continue to experience, risks related to the impact of the war in Ukraine, including increases in the cost and, in certain cases, limitations on the availability of raw and packaging materials and commodities (including oil and natural gas), supply chain and logistics challenges and foreign currency volatility. We also continue to monitor the impact of the sanctions and export controls imposed in the response to the war in Ukraine. The situation continues to evolve and significant uncertainties regarding the full impact of the war in Ukraine or the related impacts on the global economy and geopolitical relations, in general and on our business in particular, remain and may be impacted by any or all of the foregoing risks. The war in Ukraine may also heighten other risks disclosed in this Annual Report on Form 10-K, any of which could have an adverse impact on our business, results of operations, cash flows or financial condition.

Furthermore, the imposition of tariffs and/or increase in tariffs on various products by the United States and other countries have introduced greater uncertainty with respect to trade policies and government regulations affecting trade between the United States and other countries and new and/or increased tariffs have subjected, and may continue in the future to subject, us to additional costs and expenditure of resources. Major developments in trade relations, including the imposition of new or increased tariffs by the United States and/or other countries, such as China, and any emerging nationalist trends in specific countries could alter the trade environment and consumer purchasing behavior which, in turn, could have a material effect on our business, results of operations, cash flows and financial condition.

In an effort to minimize the impact on earnings of foreign currency rate movements, we engage in a combination of selling price increases, where permitted, sourcing strategies, cost-containment measures and selective hedging of foreign currency transactions. However, the impact of these measures have not and may not in the future fully offset any negative impact of foreign currency rate movements on our business, results of operations, cash flows and financial condition.

Significant competition in our industry could adversely affect our business.

We face vigorous competition worldwide, including from strong local competitors and from other large, multinational companies, some of which have greater resources than we do. In addition, the substantial growth in eCommerce has encouraged the entry of new competitors and business models.

We face competition in several aspects of our business, including pricing, promotional activities, new product introductions and expansion into new geographies and channels. Some of our competitors may spend more aggressively on or have more effective advertising and promotional activities than we do, introduce competing products more quickly and/or respond more effectively to business and economic conditions and changing consumer preferences, including by launching innovative new products. Such competition also extends to administrative and legal challenges of product claims and advertising. Our success is increasingly dependent on our ability to effectively leverage digital technology and data analytics to gain new commercial insights and develop relevant marketing and advertising to reach customers and consumers. Our ability to compete also depends on the strength of our brands and on our ability to enforce and defend our intellectual property, including patent, trademark, copyright, trade secret and trade dress rights, against infringement and legal challenges by competitors.

We may be unable to anticipate the timing and scale of such initiatives or challenges by competitors or to successfully respond to them, which could harm our business. In addition, the cost of responding to such initiatives and challenges, including management time, out-of-pocket expenses and price reductions, may affect our performance. A failure to compete effectively could adversely affect our business, results of operations, cash flows and financial condition.

Increasing dependence on key retailers in developed markets, changes in the policies of our retail trade customers, the emergence of alternative retail channels and the rapidly changing retail landscape and changing consumer preferences may adversely affect our business.

Our products are sold in a highly competitive global marketplace which has experienced increased trade concentration and the growing presence of large-format retailers, discounters and eCommerce retailers. With the growing trend toward retail trade consolidation, the substantial growth of eCommerce and the integration of traditional and digital operations at key retailers, we are increasingly dependent on certain retailers, and some of these retailers have and may continue to have greater bargaining strength than we do. They have used and may continue to use this leverage to demand higher trade discounts, allowances, slotting fees or increased investment, including through display media, paid search, preparation fees and co-op programs, which have led to and could continue to lead to reduced sales or profitability in certain markets. The loss of a key customer or a significant reduction in sales to a key customer could adversely affect our business, results of
9


operations, cash flows and financial condition. For additional information regarding our customers, see “Distribution; Raw Materials; Competition; Trademarks and Patents” in Item 1 “Business.”

We also have been and may continue to be negatively affected by changes in the policies or practices of our retail trade customers, such as inventory destocking, fulfillment requirements, limitations on access to shelf space, delisting of our products, or sustainability, supply chain or packaging standards or initiatives. For example, a determination by a key retailer that any of our ingredients should not be used in certain consumer products or that our packaging does not comply with certain requirements and standards could adversely impact our business, results of operations, cash flows and financial condition. In addition, “private label” products sold by our retail customers, which are typically sold at lower prices than branded products, are a source of competition for certain of our products.

Further, the retail landscape in many of our markets continues to evolve as a result of the substantial growth of eCommerce, changing consumer behaviors and preferences (as consumers increasingly shop online and via mobile and social applications) and the increased presence of alternative retail channels, such as subscription services and direct-to-customer businesses. The substantial growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers.

Further, consumer preferences continue to evolve due to a number of factors, including evolving consumer concerns or perceptions (whether or not valid) regarding environmental, social and governance (“ESG”) practices, including the sourcing and sustainability of packaging materials, a growing demand for natural or organic products and ingredients and ingredient transparency, evolving consumer concerns or perceptions regarding the effects of ingredients, changing consumer sentiment toward non-local products or sources and changing perceptions of and increased focus on labor and human rights and environmental impacts (including responsible sourcing, deforestation, packaging, plastic, energy and water use and waste management).

If we are not successful in continuing to adapt or to effectively react to changes in consumer behaviors, preferences or purchasing patterns and/or changing market dynamics, including customer policies or the proliferation of eCommerce and alternative retail channels, our business, results of operations, cash flows and financial condition could be adversely affected.

The growth of our business depends on the successful identification, development and launch of innovative new products.

Our growth depends on the continued success of existing products, the successful identification, development and launch of innovative new and differentiated products and the expansion into adjacent categories, channels of distribution or geographies. Our ability to launch new products, to sustain existing products and to expand into adjacent categories, channels of distribution or geographies is affected by whether we can successfully:

identify, develop and fund technological innovations;

obtain and maintain necessary intellectual property protection and avoid infringing intellectual property rights of others;

obtain approvals and registrations of regulated products, including from the FDA and other regulatory bodies in the U.S. and abroad; and

anticipate and quickly respond to the needs and preferences of consumers and customers.

The identification, development and introduction of innovative new products that drive incremental sales involves considerable costs and effort, and any new product may not generate sufficient customer and consumer interest and sales to become a profitable product or to cover the costs of its development and promotion. Our ability to achieve a successful launch of a new product could also be adversely affected by preemptive actions taken by competitors in response to the launch, such as increased promotional activities and advertising. In addition, new products may not be accepted quickly or significantly in the marketplace.

Our ability to quickly innovate to adapt and market our products and to adapt our packaging and the sustainability profile of our products to meet evolving consumer preferences is an essential part of our business strategy. The failure to
10


develop and launch successful new products or to adapt our packaging, the sustainability profile of our products or supply chain to meet such preferences could hinder the growth of our business and any delay in the development or launch of a new product could result in us not being the first to market, which could compromise our competitive position and adversely affect our business, results of operations, cash flows and financial condition. In addition, our success in launching new products is also dependent on our ability to deliver effective and efficient marketing in an evolving media landscape (including digital), which is subject to dynamic and increasingly restrictive privacy requirements.

If, in the course of identifying or developing new products, we are found to have infringed the trademark, trade secret, copyright, patent or other intellectual property rights of others, directly or indirectly, through the use of third-party ideas or technologies, such a finding could adversely affect our ability to develop innovative new products and adversely affect our business, results of operations, cash flows and financial condition. Even if we are not found to infringe a third party’s intellectual property rights, claims of infringement could adversely affect us, including by increasing costs and by delaying the launch of new products.


We face various risks related to pandemics, epidemics or similar widespread public health concerns, which may have a material adverse effect on our business, results of operations, cash flows and financial condition.

We face various risks related to pandemics, epidemics or similar widespread public health concerns, including the COVID-19 pandemic. A pandemic, epidemic or similar widespread health concern could have, and COVID-19 has had and may continue to have, a variety of impacts on our business, results of operations, cash flows and financial condition, including:

our ability to continue to maintain and support the health, safety and well-being of our employees, including key employees;

disruptions to our global supply chain, including the closure of manufacturing and distribution facilities, due to, among other things, the lack of availability of raw and packaging materials or manufacturing components; a decrease in our workforce or in the efficiency of such workforce, including as a result of illness, travel restrictions, absenteeism or governmental regulations; transportation and logistics challenges, including as a result of port and border closures and other governmental restrictions or volume and capacity restraints; or the impact of a pandemic, epidemic or other health emergencies, such as the COVID-19 pandemic on our retailers, third party suppliers, contract manufacturers, logistics providers or distributors;

volatility in the demand for and availability of our products, which may be caused by the temporary inability of our consumers to purchase our products due to illness, financial hardship, quarantine, government actions mandating the closure of our facilities, distributors or retailers and/or imposing travel or movement restrictions, shifts in demand and consumption away from more discretionary or higher priced products to lower-priced products or pantry-loading activity;

changes in purchasing patterns of our consumers, including a shift to purchasing our products online and disruptions in certain channels;

significant volatility in demand for certain of our products, which may require us to increase our production capacity or acquire additional capacity at an additional cost and expense;

failure of third parties on which we rely, including our retailers, suppliers, contract manufacturers, logistics providers, customers, commercial banks, joint venture partners and external business partners, to meet their obligations to us, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties;

significant changes in the economic and political conditions of the markets in which we operate, which could restrict our employees’ ability to work and travel, could mandate the closure of certain distributors or retailers, our offices, shared business service centers and/or operating and manufacturing facilities or otherwise could prevent us as well as our third-party partners, suppliers or customers from sufficiently staffing operations, including operations necessary for the manufacture, distribution, sale and support of our products;

11


disruptions and volatility in the global capital markets, including rising interest rates, which may increase the cost of capital and adversely impact our access to capital; and/or

volatility in foreign exchange rates and increases in the cost and availability of raw and packaging materials and transportation and logistics costs.

During the COVID-19 pandemic, many of the communities in which we manufacture, market and sell our products experienced and may in the future experience “stay at home” orders, travel or movement restrictions and other government actions to address the pandemic. While the impact of COVID-19 on our business has largely abated at this time, uncertainties continue, particularly in China where we have substantial manufacturing facilities and business, and in the travel retail channel, where we have experienced and may continue to experience disruptions particularly in our Filorga business. We have also experienced and may continue to experience certain disruptions to our global supply chain due to COVID-19, which have impacted and may continue to impact sales of and consumer access to our products. We have also witnessed and may continue to witness changes in the purchasing patterns of our customers, including a shift in many markets to purchasing our products online. COVID-19 may continue to impact consumer behavior and preferences, shopping patterns and consumption preferences. Uncertainty resulting from COVID-19 could result in an unforeseen additional disruption to our business, including our global supply chain and retailer network, and/or require us to incur additional operational costs.

These and other risks related to COVID-19 have adversely affected and may continue to adversely affect our business, results of operations, cash flows and financial condition. Furthermore, these and other impacts of COVID-19 could also have the effect of heightening many of the other risk factors included in this Item 1A, “Risk Factors,” which could adversely affect our business, results of operations, cash flows and financial condition. For additional information regarding how COVID-19 has affected or is expected to affect our business, refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Executive Overview.”

Damage to our reputation could have an adverse effect on our business.

Maintaining our strong reputation with consumers and our trade partners globally is critical to selling our branded products. Accordingly, we devote significant time and resources to programs designed to protect and preserve our reputation, such as our ethics and compliance, ESG, brand protection and product safety, regulatory and quality initiatives. Negative publicity about us, our brands, our products, our supply chain, our ingredients, our packaging, our ESG practices, or our employees, whether or not deserved, could jeopardize our reputation. Such negative publicity could relate to, among other things, health concerns, threatened or pending litigation or regulatory proceedings, labor and human rights and environmental impact (including responsible sourcing, deforestation, packaging, plastic, energy and water use and waste management) or our ESG practices. In addition, the proliferation of digital and social media has greatly increased the accessibility of information and the speed of its dissemination and the potential for negative publicity. Negative publicity, posts or comments on digital and social media, whether true or untrue, could damage our brands and our reputation. The success of our brands could also suffer if our marketing initiatives do not have the desired impact on a brand’s image or its ability to attract consumers.

Additionally, due to the scale and scope of our business, we must rely on relationships with third parties, including our suppliers, distributors, contractors, joint venture partners and other external business partners, for certain functions. While we have policies and procedures for managing these relationships, they inherently involve a lesser degree of control over business operations, compliance and ESG practices, thereby potentially increasing our reputational and legal risk.

We have taken and in the future may take certain actions to safeguard our reputation and uphold our ethical values, such as changes to how and where we sell, advertise and invest behind our products and operations, which could adversely affect our business, results of operations, cash flows and financial condition.

In addition, third parties sell counterfeit versions of our products, which are inferior or may pose safety risks. As a result, consumers of our brands could confuse our products with these counterfeit products, which could cause them to refrain from purchasing our brands in the future and in turn could impair our brand equity and adversely affect our business, results of operations, cash flows and financial condition.

12


Damage to our reputation or loss of consumer confidence in our products for these or any other reasons could adversely affect our business, results of operations, cash flows and financial condition, as well as require resources to rebuild our reputation.

Our success depends upon our ability to recruit, attract and retain key employees, including through the implementation of diversity, equity and inclusion initiatives, and the succession of senior management.

Our success largely depends on the performance of our management team and other key employees. If we are unable to recruit, attract and retain talented, highly qualified senior management and other key people, our business, results of operations, cash flows and financial condition could be adversely affected. Successfully executing organizational change, including management transitions at leadership levels of the Company and succession plans for senior management, is critical to our business success. While we follow a disciplined, ongoing succession planning process and have succession plans in place for senior management and other key executives, these do not guarantee that the services of qualified senior executives will continue to be available to us at particular moments in time. Further, changes in immigration laws and government policies, including related to the COVID-19 pandemic, have made, in certain circumstances, and may continue to make, it more difficult for us to recruit or relocate highly skilled technical, professional and management personnel to meet our business needs. Our ability to attract and retain talent has been and may continue to be impacted by challenges in the labor market, particularly in the United States, which has experienced and may continue to experience wage inflation, labor shortages and a shift toward a hybrid working model. In addition, we continue to work to advance culture change through the implementation of DE&I initiatives throughout our organization. We continue to embed new ways of working throughout the organization to, among other things, instill a growth mindset to drive innovation with focus, empowerment, experimentation and digitization. If we do not (or are perceived not to) successfully implement these initiatives, our ability to recruit, attract and retain talent may be adversely impacted.

We have pursued and may continue to pursue acquisitions and divestitures, which could adversely impact our business.

We have pursued and may continue to pursue acquisitions of brands, businesses, assets or technologies from third parties. Acquisitions and their pursuit have involved, and can involve, numerous potential risks, including, among other things:

realizing the full extent of the expected benefits or synergies as a result of a transaction, within the anticipated time frame, or at all;

successfully integrating the operations, technologies, services, products and systems of the acquired brands, assets or businesses in an effective, timely and cost-efficient manner;

receiving necessary consents, clearances and approvals in connection with a transaction;

diverting management’s attention from other business priorities;

successfully operating in new lines of business, channels of distribution or markets;

achieving distribution expansion related to products, categories and markets;

retaining key employees, partners, suppliers and customers of the acquired business;

conforming standards, controls, procedures and policies of the acquired business with our own;

developing or launching products with acquired technologies; and

other unanticipated problems or liabilities.

Moreover, acquisitions have resulted in and could in the future result in substantial additional debt, the assumption of contingent liabilities, such as litigation or earn-out obligations, or transaction costs. In addition, to the extent that the economic benefits associated with an acquisition or investment diminish in the future or the performance of an acquired
13


company or business is less robust than expected, we may be required to record additional impairments of intangible assets, including trademarks and goodwill. For example, in the fourth quarter of 2022, we took non-cash, aftertax impairment charges of $620 million, to adjust the carrying values of goodwill and intangible assets related to the Filorga skin health business. For additional information regarding recent impairment charges, refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Results of Operations - Goodwill and Intangible Asset Impairment Charges.” Any of these risks could adversely impact our reputation and our business, results of operations, cash flows and financial condition.

We have divested and may in the future periodically divest brands or businesses. These divestitures may adversely impact our business, results of operations, cash flows and financial condition if we are unable to offset the dilutive impacts from the loss of revenue associated with the divested brands or businesses, or otherwise achieve the anticipated benefits or cost savings from the divestitures. In addition, businesses under consideration for, or otherwise subject to, divestiture may be adversely impacted prior to the divestiture, which could negatively impact our business, results of operations, cash flows and financial condition.

Operational Risks

Our business results are impacted by our ability to manage disruptions in our global supply chain and/or key office facilities.

We are engaged in the manufacture and sourcing of products and materials on a global scale. Our operations and those of our suppliers, contract manufacturers or logistics providers have been and may continue to be disrupted by a number of factors, including, but not limited to:

geopolitical events, wars and military conflicts, such as the war in Ukraine;

widespread health emergencies, such as COVID-19 or other pandemics or epidemics;

strikes and other labor disputes;

disruptions in logistics;

loss or impairment of key manufacturing or distribution sites;

loss of key suppliers or contract manufacturers;

capacity constraints;

raw material and product quality or safety issues;

industrial accidents or other occupational health and safety issues;

the impact on our suppliers of tighter credit or capital markets;

the lack of availability of qualified personnel, such as truck drivers and production labor;

governmental incentives and controls (including import and export restrictions, such as new or increased tariffs, sanctions, quotas or trade barriers); and

natural disasters, including climatic events (including any potential effects of climate change) and earthquakes, tornadoes, acts of war or terrorism, political unrest or uncertainty, fires or explosions, cyber-security incidents and other external factors over which we have no control.

In addition, we purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers and new suppliers may have to be qualified under industry, governmental and/or Colgate standards, which can require additional investment and take a significant period of time. If our existing or new suppliers fail to meet such
14


standards or if we are unable to contract with suppliers on favorable terms, our business, results of operations, cash flows and financial condition could be adversely affected.

We believe that the supplies of raw and packaging materials needed to manufacture our products are adequate. In addition, we have business continuity and contingency plans in place for key manufacturing sites and contract manufacturers and the supply of raw and packaging materials. Nonetheless, a significant disruption to the manufacturing or sourcing of products or materials for any reason, including those mentioned above, have at times interrupted and could, in the future, interrupt product supply and, if not remedied, could have an adverse impact on our business, results of operations, cash flows and financial condition.

In addition, as a result of our global shared service organizational model, certain of our functions, such as finance and accounting, customer service and logistics, human resources, global information technology and data analytics are concentrated in key office facilities. A significant disruption to any of our key office facilities for any reason, including those mentioned above, could adversely affect our business, results of operations, cash flows and financial condition.

Volatility in material and other costs could adversely impact our profitability.

Raw and packaging material commodities, such as essential oils, resins, tropical oils, pulp, tallow, corn, poultry and soybeans, are subject to market price variations. Increases in the costs of and/or a reduction in the availability of commodities, energy and logistics (including trucks and containers) and other necessary services, including as a result of COVID-19 and/or the war in Ukraine, have affected and are likely to continue to adversely affect our profit margins. Inflationary pressures have also increased and may continue to increase the cost of such commodities and services. We have taken and may continue to take actions to mitigate these cost increases in the form of price increases and efforts to achieve cost efficiencies in areas such as manufacturing and distribution, or otherwise manage the exposure through sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. These actions may not, however, fully offset these higher costs and our business, results of operations, cash flows and financial condition have been and may continue to be adversely impacted. In addition, even if we are able to increase the prices of our products in response to commodity and other cost increases, we may not be able to sustain the price increases which may lead to declines in volume. If competitors do not adjust their prices or if consumers decide not to pay higher prices and forego purchasing certain of our products or switch to “private label” or lower-priced product offerings, sales declines, a deterioration in our profitability and loss of market share may occur which could adversely affect our business, results of operations, cash flows and financial condition. See “Our business results depend on our ability to manage disruptions in our global supply chain and/or key office facilities” above for additional information.

There is no guarantee that our ongoing efforts to reduce costs will be successful.

One way that we generate funds needed to support the growth of our business is through our continuous, Company-wide initiatives to lower costs and increase effective asset utilization, which we refer to as our funding-the-growth initiatives. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things. The achievement of our funding-the-growth goals depends on our ability to successfully identify and realize additional savings opportunities. Events and circumstances, such as financial or strategic difficulties, delays and unexpected costs may occur that could result in our not realizing any or all of the anticipated benefits or our not realizing the anticipated benefits on our expected timetable. If we are unable to realize the anticipated savings of our funding-the-growth initiatives, our ability to fund other initiatives and achieve our profitability goals may be adversely affected. Any failure to implement our funding-the-growth initiatives in accordance with our expectations could adversely affect our business, results of operations, cash flows and financial condition. For additional information regarding our funding-the-growth initiatives, refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Executive Overview.”

We may not fully realize the benefits that we expect from our 2022 Global Productivity Initiative.

On January 27, 2022, the Board approved a targeted productivity program (the “2022 Global Productivity Initiative”). The program is intended to reallocate resources toward our strategic priorities and faster growth businesses, drive efficiencies in our operations and streamline our supply chain to reduce structural costs. The successful implementation of the program may present organizational challenges and, in some cases, may require successful negotiations with third parties. As a result, we may not be able to fully realize all of the anticipated benefits from the 2022 Global Productivity Initiative. Events and circumstances, such as financial or strategic difficulties, delays and unexpected costs may occur that
15


could result in our not realizing all of the anticipated benefits or our not realizing such benefits on our expected timetable. In addition, changes in foreign exchange rates or in tax, labor or immigration laws may result in our not achieving the anticipated cost savings as measured in U.S. dollars. If we are unable to fully realize the anticipated savings from the 2022 Global Productivity Initiative, our ability to fund other initiatives and enhance profitability may be adversely affected. Any failure to implement the 2022 Global Productivity Initiative in accordance with our expectations could adversely affect our business, results of operations, cash flows and financial condition. For additional information regarding the 2022 Global Productivity Initiative, refer to Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Restructuring and Related Implementation Charges.”

A cyber-security incident, data breach or a failure of a key information technology system could adversely impact our business.

We rely extensively on information technology systems (“IT Systems”), including some which are managed, hosted, provided and/or used by third parties, including cloud-based service providers, and their vendors, in order to conduct our business. Our uses of these systems include, but are not limited to:

communicating within our company and with other parties, including our customers and consumers;

ordering and managing materials from suppliers;

converting materials to finished products;

receiving and processing orders from, shipping products to and invoicing our customers and consumers;

marketing products to consumers;

collecting, storing, transferring and/or processing customer, consumer, employee, vendor, investor and other stakeholder information and personal data, including, but not limited to, such data from residents of states, countries and regions with important data protection laws and regulations;

processing transactions, including but not limited to employee payroll, employee and retiree benefits and payments to customers and vendors;

hosting, processing and sharing confidential and proprietary research, intellectual property, business plans and financial information;

summarizing and reporting results of operations, including financial reporting;

managing our banking and other cash liquidity systems and platforms;

complying with legal, regulatory and tax requirements;

providing data security; and

handling other processes involved in managing our business.

Although we have a broad array of information security measures in place, our IT Systems, including those of third-party service providers with whom we have contracted, have been, and will likely continue to be, subject to computer viruses or other malicious codes, unauthorized access attempts, phishing and other cyber-attacks. Cyber-attacks and other cyber incidents are occurring more frequently, are constantly evolving in nature, are becoming more sophisticated and are being made by groups, individuals and nation states with a wide range of expertise and motives. Such cyber-attacks and cyber incidents can take many forms, including cyber extortion, social engineering, password theft or introduction of viruses or malware, such as ransomware through phishing emails. We cannot guarantee that our security efforts will prevent breaches or breakdowns of our, or our third-party service providers’, IT Systems since the techniques used in these attacks change frequently and may be difficult to detect for periods of time. In addition, although we have policies and procedures in place to ensure that all personal information collected by us or our third-party service providers is securely maintained, data leakages due to human error or intentional or unintentional conduct have occurred and likely will continue
16


to occur. Furthermore, we periodically upgrade our IT Systems or adopt new technologies. If such an upgrade or new technology does not function as designed, does not go as planned or increases our exposure to a cyber-attack or cyber incident, it may adversely impact our business, including our ability to ship products to customers, issue invoices and process payments or order raw and packaging materials. Although we have seen no material impact on our business operations from the cyber-security incidents we have experienced to date, if we suffer a significant loss or disclosure of confidential business or stakeholder information as a result of a breach of our IT Systems, including those of third-party service providers with whom we have contracted, or otherwise, we may suffer reputational, competitive and/or business harm, incur significant costs and be subject to government investigations, litigation, fines and/or damages, which may adversely impact our business, results of operations, cash flows and financial condition. In addition, while we currently maintain insurance coverage that, subject to its terms and conditions, is intended to address costs associated with certain aspects of cyber-security incidents and IT System failures, this insurance coverage may not, depending on the specific facts and circumstances surrounding an incident, cover all losses or all types of claims that arise from an incident, or the damage to our business, reputation or brands that may result from an incident.

Furthermore, while we have disaster recovery and business continuity plans in place, if our IT Systems are damaged, breached or cease to function properly for any reason, including the poor performance of, failure of or cyber-attack on third-party service providers, catastrophic events, power outages, cyber-security breaches, network outages, failed upgrades or other similar events and, if the disaster recovery and business continuity plans do not effectively resolve such issues on a timely basis, we may suffer interruptions in our ability to manage or conduct business as well as reputational harm, and may be subject to governmental investigations and litigation, any of which may adversely impact our business, results of operations, cash flows and financial condition.

Climate change and other sustainability matters could have an adverse impact on our business and results of operations.

Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases (“GHG”) in the atmosphere and its impact on global temperatures, weather patterns and the frequency and severity of natural disasters and other extreme weather conditions may adversely impact our business, results of operations, cash flows and financial condition. Specifically, the predicted effects of climate change may exacerbate challenges regarding the availability and quality of water and the cost, quality and availability of raw and packaging materials, pose physical risks to our facilities and those of our key suppliers, disrupt our global supply chain or impact demand for our products. In addition, the increased concern over climate change has resulted and is likely to continue to result in additional legal and regulatory requirements intended to, among other things, reduce or mitigate the effects of climate change and have related and may relate to, among other things, GHG emissions (e.g., carbon pricing), alternative energy policy and additional disclosure obligations. Such additional regulation may adversely affect our business, results of operations, cash flows and financial condition by increasing our compliance and manufacturing costs and/or negatively impacting our reputation if we are unable to, or are perceived (whether or not valid) not to, satisfy such requirements or expectations. Achieving our sustainability and social impact targets will require significant efforts from us and other stakeholders, such as our suppliers and other third parties. It will also require capital investment, additional expense (e.g., renewable energy costs) and the development of technology that may not currently exist. Any failure to achieve our sustainability and social impact targets or the perception (whether or not valid) that we have failed to act responsibly with respect to such matters or to effectively respond to new or additional legal or regulatory requirements regarding climate change or other sustainability matters, could result in adverse publicity and adversely affect our business and reputation. There is also increased focus, including by governmental and non-governmental organizations, investors, customers, consumers, regulators, our employees and other stakeholders on these and other sustainability and social impact matters, including responsible sourcing and deforestation, the use of plastic, energy and water, the recyclability or recoverability of packaging, including single-use and other plastic packaging, and a growing demand for natural or organic products and ingredients and ingredient transparency. Our reputation could be damaged if we do not (or are perceived not to) act responsibly with respect to sustainability matters, which could adversely affect our business, results of operations, cash flows and financial condition.

Legal and Regulatory Risks

Our business is subject to legal and regulatory risks in the U.S. and abroad.

Our business is subject to extensive legal and regulatory requirements in the U.S. and abroad. Such legal and regulatory requirements apply to most aspects of our products, including their development, ingredients, formulation, manufacture, packaging content, labeling, storage, transportation, distribution, export, import, advertising, sale and environmental impact. U.S. federal authorities, including the U.S. Food and Drug Administration (the “FDA”), the Federal Trade Commission, the Consumer Product Safety Commission, the Occupational Safety and Health Administration and the
17


Environmental Protection Agency, regulate different aspects of our business, along with parallel authorities at the state and local levels and comparable authorities overseas. In addition, our selling practices are regulated by competition law authorities in the U.S. and abroad.

New or more stringent legal or regulatory requirements, or more restrictive interpretations of existing requirements, could adversely impact our business, results of operations, cash flows and financial condition. For example, from time to time, various regulatory authorities around the world review the use of various ingredients and packaging content in consumer products. While we monitor and seek to mitigate the impact of any emerging information, a decision by a regulatory or governmental authority that any ingredient or packaging content in our products should be restricted or should otherwise be newly regulated could adversely impact our business and reputation, as could negative reactions by our consumers, trade customers or non-governmental organizations to our current or prior use of such ingredients or packaging. Additionally, an inability to develop new or reformulated products containing alternative ingredients, to obtain regulatory approval of such products or ingredients on a timely basis or to effectively market and sell such products could likewise adversely affect our business.

Because of our extensive international operations, we could be adversely affected by violations of worldwide anti-bribery laws, including those that prohibit companies and their intermediaries from making improper payments to government officials or other third parties for the purpose of obtaining or retaining business, such as the U.S. Foreign Corrupt Practices Act, and laws that prohibit commercial bribery. We are also subject to laws and sanctions imposed by the U.S. (including, without limitation, those imposed by OFAC) and/or by other jurisdictions that may prohibit us or certain of our affiliates from doing business in certain countries, or restrict the kind of business that may be conducted. While our policies mandate compliance with these laws, we cannot provide assurance that our internal control policies and procedures will always protect us from reckless or criminal acts committed by our employees, joint venture partners or agents. Violations of these laws, or allegations of such violations, could disrupt our business and adversely affect our reputation and our business, results of operations, cash flows and financial condition.

While it is our policy and practice to comply with all legal and regulatory requirements applicable to our business, findings that we are in violation of, or out of compliance with, applicable laws or regulations have subjected us to, and could subject us to, civil remedies, including fines, damages, injunctions or product recalls, or criminal sanctions, any of which could adversely affect our business, results of operations, cash flows and financial condition. Even if a claim is unsuccessful, is without merit or is not fully pursued, the cost of responding to such a claim, including management time and out-of-pocket expenses, and the negative publicity surrounding such assertions regarding our products, processes or business practices could adversely affect our reputation, brand image and our business, results of operations, cash flows and financial condition. For information regarding our legal and regulatory matters, see Item 3 “Legal Proceedings” and Note 13, Commitments and Contingencies to the Consolidated Financial Statements.

Legal claims and proceedings could adversely impact our business.

As a global company serving consumers in more than 200 countries and territories, we are and may continue to be subject to a wide variety of legal claims and proceedings, including disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Regardless of their merit, these claims can require significant time and expense to investigate and defend. Since litigation is inherently uncertain, there is no guarantee that we will be successful in defending ourselves against such claims or proceedings, or that our assessment of the materiality of these matters, including any reserves taken in connection therewith, will be consistent with the ultimate outcome of such matters. In addition, if one of our products, or an ingredient contained in our products, is perceived or found to be defective, or unsafe or have a quality issue, we have had to and may in the future need to withdraw, recall or reformulate some of our products. Whether or not a legal claim or proceeding is successful, or a withdrawal, recall or reformulation is required or advisable, such assertions could have an adverse effect on our business, results of operations, cash flows and financial condition, and the negative publicity surrounding them could harm our reputation and brand image. The resolution of, or increase in the reserves taken in connection with, one or more of these matters in any reporting period could have a material adverse effect on our business, results of operations, cash flows and financial condition for that period. See Item 3 “Legal Proceedings” and Note 13, Commitments and Contingencies to the Consolidated Financial Statements for additional information on certain of our legal claims and proceedings.


18


Financial and Economic Risks

Uncertain or unfavorable global economic conditions may adversely affect our business.

Uncertain or unfavorable global economic conditions could adversely affect our business. Unfavorable global economic conditions, such as a recession, an economic slowdown, inflation, higher interest rates and/or reduced category growth rates, including as a result of the COVID-19 pandemic and/or the war in Ukraine, have negatively impacted and could negatively impact our business and result in declining revenues, profitability and/or cash flows. Although we continue to devote significant resources to support our brands and market our products at multiple price points, during periods of economic uncertainty or unfavorable economic conditions, consumers may reduce consumption or discretionary spending and/or change their purchasing patterns by foregoing purchasing certain of our products or by switching to “private label,” or lower-priced product offerings. These changes could reduce demand for our products or result in a shift in our product mix, as consumers may choose products that sell at lower prices. Additionally, our retailers may be impacted and they may increase pressure on our selling prices or increase promotional activity for lower-priced or value offerings as they seek to maintain sales volumes and margins. Furthermore, economic conditions can cause our suppliers, distributors, contract manufacturers, logistics providers or other third-party partners to suffer financial or operational difficulties, which may impact their inability to provide us with or distribute finished product, raw and packaging materials and/or services in a timely manner or at all. In addition, we could face difficulty collecting or recovering accounts receivables from third parties facing financial or operational difficulties.

Disruptions in the credit markets or changes to our credit ratings may adversely affect our business.

While we currently generate significant cash flows from ongoing operations and have access to global credit markets through our various financing activities, a disruption or volatility in the credit markets, interest rate increases or changes to our credit rating or changes that may result from the continued implementation of new benchmark rates that are replacing the London Interbank Offered Rate (“LIBOR”) could negatively impact the availability or cost of funding. Reduced access to credit or increased costs could adversely affect our liquidity and capital resources or significantly increase our cost of capital. In addition, if any financial institutions that hold our cash or other investments or that are parties to our undrawn revolving credit facility supporting our commercial paper programs or other financing arrangements, such as interest rate, foreign exchange or commodity hedging instruments, were to declare bankruptcy or become insolvent, they may be unable to perform under their agreements with us. This could leave us with reduced borrowing capacity or unhedged against certain interest rate, foreign currency or commodity price exposures. In addition, tighter or more volatile credit markets may lead to business disruptions for certain of our suppliers, contract manufacturers or trade customers which could, in turn, adversely impact our business, results of operations, cash flows and financial condition.

Tax matters, including changes in tax rates, disagreements with taxing authorities and imposition of new taxes could negatively impact our business.

We are subject to taxes in the U.S. and in the foreign jurisdictions where we do business. Due to economic and political conditions, tax rates in the U.S. and various foreign jurisdictions have been and may be subject to significant change. Changes in the mix of our earnings between countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities related to changes in tax rates, changes in tax laws, including how existing tax laws are interpreted or enforced, or contemplated changes in long-standing tax principles, if finalized and adopted, could adversely impact our future effective tax rate and business, results of operations, cash flows and financial condition. For example, long-standing international tax norms that determine each country’s jurisdiction to tax cross-border international trade are evolving as a result of a multilateral project, the Base Erosion and Profit Shifting Project (the “BEPS Project”), that has established new principles and reporting requirements recommended by the member countries of the Organization for Economic Cooperation and Development (the “OECD”). In connection with the BEPS Project, companies are required to disclose more information to tax authorities on operations around the world, which may lead to greater audit scrutiny of profits earned in countries outside of the U.S. Many jurisdictions have already enacted legislation and adopted policies resulting from the BEPS Project. The OECD, is also addressing the challenges of the digitization of the global economy with plans to redefine jurisdictional taxation rights in market countries and establish a global minimum tax. In addition, we are evaluating the impact of recent legislation in the U.S., such as the Inflation Reduction Act of 2022 that, among other things, provides for a corporate alternative minimum tax, and in the European Union, such as the Minimum Tax Directive that provides for a minimum level of taxation for certain large corporations in every jurisdiction in which they operate. As these and other tax laws and related regulations change, our business, results of operations, cash flows and financial condition could be materially impacted. For more information regarding recent legislation, refer to Part II, Item 7
19


"Management's Discussion and Analysis of Financial Condition and Results of Operations - Results of Operations - Income Taxes."

Furthermore, we are subject to regular reviews, examinations and audits by the Internal Revenue Service and other taxing authorities with respect to taxes inside and outside of the U.S. Although we believe our tax positions are reasonable, when a taxing authority disagrees with the positions we have taken, we have faced and in the future may face additional tax liabilities, including interest and penalties, in excess of reserves. The payment of such additional amounts upon final adjudication of any disputes could adversely impact our business, results of operations, cash flows and financial condition.















20


ITEM 1B.    UNRESOLVED STAFF COMMENTS

None.

21


ITEM 2.    PROPERTIES

We own or lease approximately 320 properties, which include manufacturing, distribution, research and office facilities worldwide. Our corporate headquarters is located in a leased property at 300 Park Avenue, New York, New York.

In the U.S., we operate in approximately 80 properties, of which 16 are owned. Major U.S. manufacturing and warehousing facilities used by the Oral, Personal and Home Care product segment of our business are located in Ohio, South Carolina and Tennessee. The Pet Nutrition segment has major manufacturing and warehousing facilities in Indiana, Kansas, Kentucky, Ohio, Oklahoma and South Carolina.

Overseas, we operate in approximately 240 properties, of which 58 are owned, in over 80 countries. Major overseas manufacturing and warehousing facilities used by the Oral, Personal and Home Care product segment of our business are located in Australia, Brazil, China, Colombia, France, Greece, Guatemala, India, Italy, Mexico, Poland, South Africa, Thailand, Turkiye, Venezuela and Vietnam. The Pet Nutrition segment has major manufacturing and warehousing facilities in the Czech Republic, Italy and the Netherlands.

The primary research center for Oral Care and Personal Care products is located in New Jersey, the primary research center for Home Care products is located in Mexico and the primary research center for Pet Nutrition products is located in Kansas. Our global data center is also located in New Jersey.

We have shared business service centers in India, Mexico and Poland, which are located in leased properties.

All of the facilities we operate are well maintained and adequate for the purpose for which they are intended.


22


ITEM 3.    LEGAL PROCEEDINGS

For information regarding legal proceedings, refer to Note 13, Commitments and Contingencies to the Consolidated Financial Statements included in Part IV, Item 15 of this report.

ITEM 4.     MINE SAFETY DISCLOSURES

Not applicable.


23


PART II

ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

For information regarding the market for the Company’s common stock, including stock price performance graphs, refer to “Market Information” included in Part IV, Item 15 of this report. For information regarding the securities authorized for issuance under our equity compensation plans, refer to “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” included in Part III, Item 12 of this report.

As of December 31, 2022, the number of common shareholders of record was 17,468.

Issuer Purchases of Equity Securities

On March 10, 2022, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2022 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the share repurchase activity for the three months in the quarter ended December 31, 2022:
Month
Total Number of Shares Purchased(1)
Average Price Paid per Share
Total Number of Shares Purchased
as Part of Publicly Announced Plans or Programs(2)
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3)
 (in millions)
October 1 through 31, 20222,911,468 $71.56 2,909,283 4,172 
November 1 through 30, 20221,430,528 $74.88 1,426,840 4,065 
December 1 through 31, 2022985,497 $77.86 977,500 3,989 
Total5,327,493 $73.62 5,313,623  
_______
(1)Includes share repurchases under the 2022 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.
(2)The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 13,870 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.
(3)Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of December 31, 2022.


ITEM 6.    [Reserved]


24

(Dollars in Millions Except Per Share Amounts)
ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Executive Overview

Business Organization

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate”) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. We seek to deliver sustainable, profitable growth and superior shareholder returns, as well as to provide Colgate people with an innovative and inclusive work environment. We do this by developing and selling products globally that make people’s and their pets’ lives healthier and more enjoyable and by embracing our sustainability and social impact and diversity, equity and inclusion (“DE&I”) strategies across our organization.

We are tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, we follow a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which we compete, we prioritize our efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable, profitable long-term growth.

Operationally, we are organized along geographic lines with management teams having responsibility for the business and financial results in each region. We compete in more than 200 countries and territories worldwide with established businesses in all regions contributing to our sales and profitability. Approximately two-thirds of our Net sales are generated from markets outside the U.S., with approximately 45% of our Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce our exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and eCommerce retailers, wholesalers, distributors, dentists and skin health professionals. Through Hill’s Pet Nutrition, we also compete on a worldwide basis in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and eCommerce retailers. We also sell certain of our products direct-to-consumer. We are engaged in manufacturing and sourcing of products and materials on a global scale and have major manufacturing facilities, warehousing facilities and distribution centers in every region around the world.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. In addition, we review market share and other data to assess how our brands are performing within their categories on a global and regional basis. The monitoring of these indicators and our Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures and the Company’s use of market share data and the limitations of such data, see “Non-GAAP Financial Measures” and “Market Share Information” below.














25

(Dollars in Millions Except Per Share Amounts)
COVID-19

The COVID-19 pandemic and government steps to reduce the spread and address the impact of COVID-19 have had and continue to have an impact on the way people live, work, interact and shop. During the COVID-19 pandemic, many of the communities in which we manufacture, market and sell our products experienced and may in the future experience “stay at home” orders, travel or movement restrictions and other government actions to address the pandemic. While the impact of COVID-19 on our business has largely abated at this time, uncertainties continue, particularly in China where we have substantial manufacturing facilities and business, and in the travel retail channel, where we have experienced and may continue to experience disruptions particularly in our Filorga business. We have also experienced certain disruptions to our global supply chain due to COVID-19, which have impacted and may continue to impact sales of and consumer access to our products. In addition, we have witnessed changes in the purchasing patterns of our customers, including a shift in many markets to purchasing our products online. COVID-19 may continue to impact consumers’ behavior, shopping patterns and consumption preferences.

While we currently expect to be able to continue operating our business as described above, uncertainty resulting from COVID-19 could result in unforeseen additional disruptions to our business, including our global supply chain and retailer network, and/or require us to incur additional operational costs.

For more information about the anticipated COVID-19 impact, see “Outlook” below.

The War in Ukraine

The war in Ukraine, and the related geopolitical tensions, have had and continue to have a significant impact on our operations in Ukraine and Russia, though it has not been material to our Consolidated Financial Statements. The safety of our employees and partners in Ukraine has been and remains our first priority. While our ability to do business in Ukraine has been significantly impacted, we remain committed to rebuilding our business there and to providing access to essential products to people in the region. We have suspended the importation and sales of all products in Russia other than essential health and hygiene products for everyday use and ceased all capital investments and media activities in Russia. While these actions have impacted our Eurasia business, they have not had a material impact on our consolidated results of operations, cash flow or financial condition. In 2022, our Eurasia business constituted approximately 2% of our consolidated net sales and approximately 3% of our consolidated operating profit (the majority of which was Russia). We also continue to monitor the impact of sanctions and export controls imposed in response to the war in Ukraine. The situation is rapidly evolving and significant uncertainties remain regarding the full impact of the war and the related impact on the global economy and geopolitical relations generally, and on our business in particular. We have seen and expect to continue to see the war’s impact on the global economy and our business including, among other things, the cost of raw and packaging materials and commodities (including the price of oil and natural gas), supply chain and logistics challenges and foreign currency volatility. For more information about factors that could impact our business, including due to the war in Ukraine, refer to Part I, Item 1A “Risk Factors” of this Annual Report on Form 10-K.






















26

(Dollars in Millions Except Per Share Amounts)
Business Strategy

To achieve our business and financial objectives, we are focused on driving organic sales growth and long-term profitable growth through science-led, core and premium innovation; pursuing higher-growth adjacent categories and segments; expanding in faster-growing channels and markets and delivering margin expansion through operating leverage and efficiency. We continue to prioritize our investments in high growth segments within our Oral Care, Personal Care and Pet Nutrition businesses. We are also seeking to maximize the impact of our environmental, social and governance programs and leading in the development of human capital, including our sustainability and social impact and DE&I strategies, which we are working to integrate across our organization. We are strengthening and leveraging our capabilities in areas such as innovation, digital, eCommerce and data and analytics, enabling us to be more responsive in today’s rapidly changing world. In particular, we believe our digital transformation is of paramount importance to our success going forward. We continue to invest behind our brands, including through advertising, and to develop initiatives to build strong relationships with consumers, dental, veterinary and skin health professionals and traditional and eCommerce retailers. We also continue to broaden our eCommerce offerings, including direct-to-consumer and subscription services. We continue to believe that growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for our products.

We are also changing the way we work to drive growth and how we approach innovation with focus, empowerment, experimentation and digitization to respond to the dynamic retail landscape and the evolving preferences of our customers and consumers. The retail landscape, the ease of new entrants into the market in many of our categories and the evolving preferences of our customers and consumers demand that we work differently and faster in an agile, authentic and culturally relevant manner to drive innovation.

The investments needed to drive growth are supported through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as our funding-the-growth initiatives, we seek to become even more effective and efficient throughout our businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification.

Significant Items Impacting Comparability

During the fourth quarter of 2022, we recorded a non-cash charge of $721 pretax ($620 aftertax) to adjust the carrying values of goodwill and intangible assets related to the Filorga skin health business. The impairment was due primarily to the continued impact of the COVID-19 pandemic on the Filorga business, particularly in China, as a result of government restrictions and reduced consumer mobility, which negatively impacted consumption in the duty-free, travel retail and pharmacy channels, and the impact of significantly higher interest rates. See Note 5, Goodwill and Other Intangible Assets to the Consolidated Financial Statements for further information.

On September 30, 2022, the Company acquired a business for a purchase price, as adjusted, of $719, which operates three dry pet food manufacturing plants in the United States, from Red Collar Pet Foods Holdings, Inc. and Red Collar Pet Foods Holdings, L.P. (collectively, “Red Collar Pet Foods”) to further support the global growth of the Hill’s Pet Nutrition business. See Note 3, Acquisitions to the Consolidated Financial Statements for additional information.

In July 2022, one of the Company’s subsidiaries in Asia Pacific completed the sale of land and recognized a pretax gain of $47 ($15 aftertax attributable to the Company).

On January 27, 2022, the Company’s Board of Directors (the “Board”) approved a targeted productivity program (the “2022 Global Productivity Initiative”). The program is intended to reallocate resources towards our strategic priorities and faster growth businesses, drive efficiencies in our operations and streamline our supply chain to reduce structural costs. Implementation of the 2022 Global Productivity Initiative, which is expected to be substantially completed by mid-year 2024, is estimated to result in cumulative pretax charges, once all phases are approved and implemented, in the range of $200 to $240 ($170 to $200 aftertax). Annualized pretax savings are projected to be in the range of $90 to $110 ($70 to $85 aftertax), once all projects are approved and implemented. For more information regarding the 2022 Global Productivity Initiative, see “Restructuring and Related Implementation Charges” below.

In the year ended December 31, 2022, we incurred pretax costs of $110 (aftertax costs of $87) resulting from the 2022 Global Productivity Initiative.
27

(Dollars in Millions Except Per Share Amounts)
In the fourth quarter of 2021, we recorded a non-cash charge of $571 pretax ($518 aftertax) to adjust the carrying values of goodwill and indefinite-lived intangible assets related to the Filorga skin health business. The impairment was due primarily to the impact of the COVID-19 pandemic on the Filorga business as a result of government restrictions and reduced consumer mobility, which negatively impacted consumption in the duty-free, travel retail and pharmacy channels. See Note 5, Goodwill and Other Intangible Assets to the Consolidated Financial Statements for further information.

In 1990, our Canadian subsidiary (“CP Canada”), issued C$145 of Canadian dollar-denominated unsecured unsubordinated 12.85% guaranteed notes due October 4, 2030 (the “Canada notes”). In the third quarter of 2021, CP Canada redeemed the Canada notes and recorded a loss on the early extinguishment of debt of $75 pretax ($55 aftertax), which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.

In 2019, we received a favorable judgment regarding certain value-added tax previously paid in Brazil. As a result of this favorable judgment, the Company filed an application with the Brazilian government to recover value-added tax previously paid and recorded a benefit. In May 2021, the Brazilian Supreme Court issued a clarifying ruling allowing a higher deduction of state value-added tax when determining the taxable base. In light of this ruling, we recorded an additional benefit of $26 pretax ($20 aftertax) in the year ended December 31, 2021.








































28

(Dollars in Millions Except Per Share Amounts)
Outlook

Looking forward, we expect global macroeconomic, political and market conditions to remain challenging, including as a result of inflation and rising interest rates. During the year ended December 31, 2022, all of our divisions experienced significantly higher raw and packaging material costs. We also incurred increased logistics costs due to volume and capacity constraints in the shipping and logistics industry, higher eCommerce demand and the war in Ukraine. We expect this difficult cost environment to continue in 2023. We are taking additional pricing to try to offset these increases in raw and packaging materials and logistics costs. This may, in turn, negatively impact consumer demand for our products. Additionally, inflation is impacting the broader economy with consumers around the world facing widespread rising prices as well as rising interest rates resulting from measures to address inflation. Such inflation and rising interest rates may negatively impact consumer consumption or discretionary spending and/or change their purchasing patterns by foregoing purchasing certain of our products or by switching to “private label” or lower-priced product offerings. Although we continue to devote significant resources to support our brands and market our products at multiple price points, these changes could reduce demand for and sales volumes of our products or result in a shift in our product mix from higher margin to lower margin product offerings. In light of this challenging environment, we expect increased volatility across all of our categories and it is therefore difficult to predict category growth rates in the near term.

Given that approximately two-thirds of our Net sales originate in markets outside the U.S., we have experienced and will likely continue to experience volatile foreign currency fluctuations. As discussed above, we have also experienced higher raw and packaging material and logistics costs. While we have taken, and will continue to take, measures to mitigate the effect of these conditions, such as the 2022 Global Productivity Initiative and our funding-the-growth and revenue growth management initiatives, including additional pricing, in the current environment, it may become increasingly difficult to implement certain of these mitigation strategies. Should these conditions persist, they could adversely affect our future results.

While the global marketplace in which we operate has always been highly competitive, we continue to experience heightened competitive activity in certain markets from strong local competitors, from other large multinational companies, some of which have greater resources than we do, and from new entrants into the market in many of our categories. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion.

We have been negatively affected by changes in the policies and practices of our trade customers in key markets, such as inventory destocking, fulfillment requirements, limitations on access to shelf space, delisting of our products and certain sustainability, supply chain and packaging standards or initiatives. In addition, the retail landscape in many of our markets continues to evolve as a result of the continued growth of eCommerce, changing consumer preferences (as consumers increasingly shop online and via mobile and social applications) and the increased presence of alternative retail channels, such as subscription services and direct-to-consumer businesses. We plan to continue to invest behind our digital and analytics capabilities and higher growth businesses. The substantial growth in eCommerce and the emergence of alternative retail channels have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers.

We continue to closely monitor the impact of the war in Ukraine, COVID-19 and the challenging market conditions discussed above on our business and the related uncertainties and risks. While we have taken, and will continue to take, measures to mitigate the effects of these conditions, we cannot estimate with certainty the full extent of their impact on our business, results of operations, cash flows and/or financial condition. For more information about factors that could impact our business, see “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K.

We believe that we are well prepared to meet the challenges ahead due to our strong financial condition, experience operating in challenging environments, resilient global supply chain, dedicated and diverse global team and focused business strategy. Our strategy is based on driving organic sales growth and long-term profitable growth through science-led, core and premium innovation; pursuing higher-growth adjacent categories and segments, expanding in faster growing channels and markets and delivering margin expansion through operating leverage and efficiency. We are also seeking to maximize the impact of our environmental, social and governance programs and leading in the development of human capital, including our sustainability and social impact and DE&I strategies. Our commitment to these priorities, the strength of our brands, the breadth of our global footprint and a commitment to profitability and driving efficiency in cash generation should position us well to manage through the challenges we face and increase shareholder value over time.

29

(Dollars in Millions Except Per Share Amounts)
Results of Operations

This section of this Annual Report on Form 10-K generally discusses 2022 and 2021 items and year-to-year comparisons between 2022 and 2021. Discussions of 2020 items and year-to-year comparisons between 2021 and 2020 that are not included in this Annual Report on Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

Net Sales

Worldwide Net sales were $17,967 in 2022, up 3.0% from 2021, due to net selling price increases of 9.5%, partially offset by volume declines of 2.0% and negative foreign exchange of 4.5%. Acquisitions contributed 0.5% to volume. Organic sales (Net sales excluding, as applicable, the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure as discussed below, increased 7.0% in 2022.

Net sales in the Oral, Personal and Home Care product segment were $14,254 in 2022, up 1.0% from 2021, due to net selling price increases of 9.0%, partially offset by volume declines of 3.5%, and negative foreign exchange of 4.5%. Organic sales in the Oral, Personal and Home Care product segment increased 5.5% in 2022.

The increase in organic sales in 2022 versus 2021 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and underarm protection categories, partially offset by organic sales declines in the skin care category. The increase in Home Care was primarily due to organic sales growth in the fabric softener and surface cleaner categories.

The Company’s share of the global toothpaste market was 39.8% for full year 2022, up 0.5 share points from full year 2021, and its share of the global manual toothbrush market was 31.7% for full year 2022, up 0.7 share points from full year 2021. Full year 2022 market shares in toothpaste were up in Europe and were flat in North America, Latin America, Asia Pacific and Africa/Eurasia versus full year 2021. In the manual toothbrush category, full year 2022 market shares were up in North America, down in Latin America and were flat in Europe, Asia Pacific and Africa/Eurasia versus full year 2021. For additional information regarding the Company’s use of market share data and limitations of such data, see “Market Share Information” below.

Net sales for Hill’s Pet Nutrition were $3,713 in 2022, an increase of 12.0% from 2021, driven by volume growth of 4.0% and net selling price increases of 11.5%, partially offset by negative foreign exchange of 3.5%. Acquisitions contributed 2.5% to volume. Organic sales for Hill’s Pet Nutrition increased 13.0% in 2022.

The increase in organic sales in 2022 versus 2021 was due to increases in organic sales in the Science Diet and Prescription Diet categories.

30

(Dollars in Millions Except Per Share Amounts)
Gross Profit/Margin

Worldwide Gross profit decreased 1% to $10,248 in 2022 from $10,375 in 2021, reflecting a decrease of $452 resulting from lower Gross profit margin and an increase of $325 resulting from higher Net sales.

Worldwide Gross profit margin decreased to 57.0% in 2022 from 59.6% in 2021. This decrease in Gross profit margin was primarily due to higher raw and packaging material costs (810 bps), partially offset by higher pricing (360 bps) and cost savings from the Company’s funding-the-growth initiatives (220 bps).
20222021
Gross profit$10,248 $10,375 
20222021Basis Point Change
Gross profit margin57.0 %59.6 %(260)

31

(Dollars in Millions Except Per Share Amounts)
Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 2% to $6,565 in 2022 from $6,407 in 2021. Selling, general and administrative expenses in 2022 included charges resulting from the 2022 Global Productivity Initiative. Excluding charges resulting from the 2022 Global Productivity Initiative, Selling, general and administrative expenses increased to $6,560 in 2022 from $6,407 in 2021, reflecting higher overhead expenses of $177 and decreased advertising investment of $24.

Selling, general and administrative expenses as a percentage of Net sales decreased to 36.5% in 2022 from 36.8% in 2021. This decrease was due to decreased advertising investment (50 bps), partially offset by higher overhead expenses (20 bps), both as a percentage of Net sales. Higher overhead expenses were driven by higher logistics costs (70 bps), partially offset by overhead efficiencies (50 bps). In 2022, advertising investment decreased as a percentage of Net sales to 11.1% from 11.6% in 2021 and decreased by 1.2% in absolute terms to $1,997 as compared with $2,021 in 2021.

20222021
Selling, general and administrative expenses, GAAP$6,565 $6,407 
2022 Global Productivity Initiative(5)— 
Selling, general and administrative expenses, non-GAAP$6,560 $6,407 

20222021Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales36.5 %36.8 %(30)


32

(Dollars in Millions Except Per Share Amounts)
Other (Income) Expense, Net

Other (income) expense, net was $69 and $65 in 2022 and 2021, respectively. Other (income) expense, net in 2022 included charges resulting from the 2022 Global Productivity Initiative, a gain on the sale of land in Asia Pacific and acquisition-related costs. Other (income) expense, net in 2021 included a benefit related to a value-added tax matter in Brazil.
20222021
Other (income) expense, net, GAAP$69 $65 
2022 Global Productivity Initiative(90)— 
Gain on the sale of land in Asia Pacific47 — 
Acquisition-related costs (19)— 
Value-added tax matter in Brazil— 26 
Other (income) expense, net, non-GAAP$$91 

Excluding the items described above in both periods, as applicable, Other (income) expense, net was $7 in 2022 and $91 in 2021, comprised of the following:
20222021
Amortization of intangible assets$80 $89 
Equity income(12)(12)
Gains from marketable securities and other assets(22)(8)
Indirect tax refunds(14)(5)
Other, net(25)27 
Total Other (income) expense, net$$91 


Goodwill and Intangible Assets Impairment Charges

In the fourth quarter of 2022, the Company made revisions to the internal forecasts relating to its Filorga reporting unit due primarily to the continued impact of the COVID-19 pandemic, particularly in China, as a result of government restrictions and reduced consumer mobility, which negatively impacted consumption in the duty-free, travel retail and pharmacy channels. The Company concluded that the changes in circumstances in this reporting unit and the impact of significantly higher interest rates triggered the need for an interim impairment review of its indefinite-lived trademark, goodwill and long-lived assets which consists primarily of customer relationships. As a result of the interim impairment test, the Company concluded that the carrying value of the trademark and customer relationships exceeded their estimated fair value and recorded impairment charges of $300 and $89, respectively, reducing their carrying values to $257 and $118, respectively, as of December 31, 2022. After adjusting the carrying values of the trademark and customer relationship intangible assets, the Company completed a quantitative impairment test for goodwill and recorded a goodwill impairment charge of $332 in the Filorga reporting unit, reducing the carrying value of goodwill to $214 as of December 31, 2022.

In the fourth quarter of 2021, the Company made revisions to the internal forecasts relating to its Filorga reporting unit due primarily to the impact of the COVID-19 pandemic on the Filorga skin health business as a result of government restrictions and reduced consumer mobility, which negatively impacted consumption in the duty-free, travel retail and pharmacy channels. The Company performed an impairment review and concluded that the carrying value of the trademark exceeded its estimated fair value, and recorded an impairment charge of $204, reducing the carrying value to approximately $588. After adjusting the carrying value of the trademark, the Company completed a quantitative impairment test for goodwill and recorded a goodwill impairment charge of $367 in the Filorga reporting unit, reducing the carrying value of goodwill to approximately $577.

The Company continues to believe in the strength of the Filorga brand and is confident about its growth opportunities. See Note 5, Goodwill and Other Intangible Assets to the Consolidated Financial Statements for further information.
33

(Dollars in Millions Except Per Share Amounts)
Operating Profit

Operating profit decreased 13% to $2,893 in 2022 from $3,332 in 2021. In 2022, Operating profit included goodwill and intangible assets impairment charges related to the Filorga reporting unit, charges resulting from the 2022 Global Productivity Initiative, a gain on the sale of land in Asia Pacific and acquisition-related costs. In 2021, Operating profit included goodwill and intangible assets impairment charges related to the Filorga reporting unit and a benefit related to a value-added tax matter in Brazil. Excluding these items in both periods, as applicable, Operating profit decreased 5% to $3,681 in 2022 from $3,877 in 2021.

    Operating profit margin was 16.1% in 2022, a decrease of 300 bps compared with 19.1% in 2021. Excluding the items described above in both periods, as applicable, Operating profit margin was 20.5% in 2022, a decrease of 180 bps from 22.3% in 2021. This decrease in Operating profit in 2022 was due to a decrease in Gross profit (260 bps), partially offset by a decrease in Other (income) expense, net (50 bps) and a decrease in selling, general and administrative expenses (30 bps), all as a percentage of Net sales.
20222021% Change
Operating profit, GAAP$2,893 $3,332 (13)%
Goodwill and intangible assets impairment charges721 571 
2022 Global Productivity Initiative95 — 
Gain on the sale of land in Asia Pacific(47)— 
Acquisition-related costs19 — 
Value-added tax matter in Brazil— (26)
Operating profit, non-GAAP$3,681 $3,877 (5)%
20222021Basis Point Change
Operating profit margin, GAAP16.1 %19.1 %(300)
Goodwill and intangible assets impairment charges4.0 %3.4 %
2022 Global Productivity Initiative0.5 %— %
Gain on the sale of land in Asia Pacific(0.2)%— %
Acquisition-related costs0.1 %— %
Value-added tax matter in Brazil— %(0.2)%
Operating profit margin, non-GAAP20.5 %22.3 %(180)


Non-Service Related Postretirement Costs

Non-service related postretirement costs were $80 in 2022 compared to $70 in 2021. In 2022, Non-service related postretirement costs included charges resulting from the 2022 Global Productivity Initiative. Excluding charges resulting from the 2022 Global Productivity Initiative, Non-service related postretirement costs were $65 in 2022 compared to $70 in 2021.
20222021
Selling, general and administrative expenses, GAAP$80 $70 
2022 Global Productivity Initiative(15)— 
Selling, general and administrative expenses, non-GAAP$65 $70 






34

(Dollars in Millions Except Per Share Amounts)
Interest (Income) Expense, Net

Interest (income) expense, net was $153 in 2022 compared to $175 in 2021. In 2021, Interest (income) expense, net included a loss on the early extinguishment of debt. Excluding the loss on the early extinguishment of debt, Interest (income) expense, net was $153 in 2022 compared to $100 in 2021, primarily due to higher average interest rates on debt and higher debt balances.

20222021
Interest (income) expense, net, GAAP$153 $175 
Loss on early extinguishment of debt— (75)
Interest (income) expense, net, non-GAAP$153 $100 

35

(Dollars in Millions Except Per Share Amounts)
Income Taxes

The effective income tax rate was 26.1% in 2022 and 24.3% in 2021. As reflected in the table below, the non-GAAP effective income tax rate was 23.3% in 2022 and 22.0% in 2021.
2022
Income Before Income Taxes
Provision For Income Taxes(1)
Effective Income Tax Rate(2)
As Reported GAAP$2,660 $693 26.1 %
Goodwill and intangible assets impairment charges721 101 (2.6)%
2022 Global Productivity Initiative110 22 (0.1)%
Gain on the sale of land in Asia Pacific(47)(11)— %
Acquisition-related costs19 (0.1)%
Non-GAAP$3,463 $808 23.3 %
2021
Income Before Income Taxes
Provision For Income Taxes(1)
Effective Income Tax Rate(2)
As Reported GAAP$3,087 $749 24.3 %
Goodwill and intangible assets impairment charges571 53 (2.1)%
Loss on early extinguishment of debt75 20 (0.3)%
Value-added tax matters in Brazil(26)(6)0.1 %
Non-GAAP$3,707 $816 22.0 %
_______
(1)     The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2)     The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.


The increase in the Companys full year effective tax rate before discrete period items is primarily driven by the impact of recently finalized U.S. tax regulations, which place greater restrictions on foreign taxes that are creditable against U.S. taxes on foreign-sourced income.
The effective income tax rate in all years benefited from tax planning associated with the Company's global business initiatives.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was enacted, which among other things, implements a 15% minimum tax on book income of certain large corporations effective for years beginning after December 31, 2022. Based on the Company’s preliminary analysis, the IRA is not expected to have a material impact on the Company’s Consolidated Financial Statements. The Company will continue to evaluate the impact of this law as additional guidance and clarification becomes available.

Additionally, on December 15, 2022, the 27 member states of the European Union (“EU”) reached an agreement on a minimum level of taxation for certain large corporations to pay a minimum corporate tax rate of 15% in every jurisdiction in which they operate. This agreement, which is known as the Minimum Taxation Directive, must be transposed into the laws of all EU member states by December 31, 2023. The Company is currently evaluating the impact of this Directive on the Company’s Consolidated Financial Statements.

The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the Internal Revenue Service (the “IRS”) and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations. In light of a recent U.S. Tax Court ruling subsequent to December 31, 2022 in favor of the IRS against an unrelated party on a similar
36

(Dollars in Millions Except Per Share Amounts)
matter, the Company is in the process of reassessing its position as it relates to this matter. The Company is currently under audit by the IRS, where the same matter is being discussed, for the years 2014 through 2018. The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $145, which is not included in our uncertain tax positions. Refer to Note 11, Income Taxes to the Consolidated Financial Statements for further discussion of the Company’s tax matters.

Net income attributable to Colgate-Palmolive Company and Earnings per share

Net income attributable to Colgate-Palmolive Company was $1,785, or $2.13 per share on a diluted basis, in 2022, a decrease from $2,166, or $2.55 per share on a diluted basis, in 2021. In 2022, Net income attributable to Colgate-Palmolive Company included goodwill and intangible assets impairment charges, charges resulting from the 2022 Global Productivity Initiative, a gain on the sale of land in Asia Pacific and acquisition-related costs. In 2021, Net income attributable to Colgate-Palmolive Company included goodwill and intangible assets impairment charges, a loss on the early extinguishment of debt and a benefit related to a value-added tax matter in Brazil.

Excluding the items described above in both periods, as applicable, Net income attributable to Colgate-Palmolive Company decreased 8% to $2,493 in 2022 from $2,719 in 2021, and Earnings per common share on a diluted basis decreased 7% to $2.97 in 2022 from $3.21 in 2021.
2022
Income Before Income Taxes
Provision For Income Taxes(1)
Net Income Including Noncontrolling InterestsLess: Income Attributable To Noncontrolling InterestsNet Income Attributable to Colgate-Palmolive Company
Diluted Earnings Per Share(2)
As Reported GAAP$2,660 $693 $1,967 $182 $1,785 $2.13 
Goodwill and intangible assets impairment charges721 101 620 — 620 0.74 
2022 Global Productivity Initiative110 22 88 87 0.10 
Gain on the sale of land in Asia Pacific(47)(11)(36)(21)(15)(0.02)
Acquisition-related costs19 16 — 16 0.02 
Non-GAAP$3,463 $808 $2,655 $162 $2,493 $2.97 
2021
Income Before Income Taxes
Provision For Income Taxes(1)
Net Income Including Noncontrolling InterestsLess: Income Attributable To Noncontrolling InterestsNet Income Attributable to Colgate-Palmolive Company
Diluted Earnings Per Share(2)
As Reported GAAP$3,087 $749 $2,338 $172 $2,166 $2.55 
Goodwill and intangible assets impairment charges571 53 518 — 518 0.61 
Loss on early extinguishment of debt75 20 55 — 55 0.07 
Value-added tax matters in Brazil(26)(6)(20)— (20)(0.02)
Non-GAAP$3,707 $816 $2,891 $172 $2,719 $3.21 
_______
(1)     The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2)     The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
37

(Dollars in Millions Except Per Share Amounts)
Segment Results

The Company markets its products in over 200 countries and territories throughout the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.

Oral, Personal and Home Care

    North America
 20222021% Change
Net sales$3,816 $3,694 3.5 %
Operating profit$761 $754 %
% of Net sales19.9 %20.4 %(50)bps

Net sales in North America increased 3.5% in 2022 to $3,816, driven by net selling price increases of 5.5%, partially offset by volume declines of 2.0%, while foreign exchange was flat. Organic sales in North America increased 3.5% in 2022. The organic sales growth was led by the United States.

The increase in organic sales in North America in 2022 versus 2021 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and liquid hand soap categories, partially offset by organic sales declines in the skin care category. The increase in Home Care was primarily due to organic sales growth in the surface cleaner and hand dish categories.

Operating profit in North America increased 1% in 2022 to $761, while as a percentage of Net sales it decreased 50 bps to 19.9%. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (60 bps), partially offset by a decrease in Selling, general and administrative expenses (40 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (550 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (220 bps) and higher pricing. This decrease in Selling, general and administrative expenses was due to lower overhead expenses (40 bps), as overhead efficiencies (60 bps) more than offset higher logistics costs (20 bps).





    
38

(Dollars in Millions Except Per Share Amounts)
    Latin America
 20222021% Change
Net sales$3,982 $3,663 8.5 %
Operating profit$1,108 $1,012 10 %
% of Net sales27.8 %27.6 %20 bps

Net sales in Latin America increased 8.5% in 2022 to $3,982, driven by net selling price increases of 15.5%, partially offset by volume declines of 5.0% and negative foreign exchange of 2.0%. Organic sales in Latin America increased 10.5% in 2022. Organic sales growth was led by Mexico, Brazil, Argentina and Colombia.
The increase in organic sales in Latin America in 2022 versus 2021 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap and underarm protection categories. The increase in Home Care was primarily due to organic sales growth in the surface cleaner and fabric softener categories.

Operating profit in Latin America increased 10% in 2022 to $1,108, or 20 bps to 27.8% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was due to a decrease in Selling, general and administrative expenses (40 bps) and a decrease in Other (income) expense, net (140 bps), partially offset by a decrease in Gross profit (160 bps), all as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (1,040 bps), which were partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives (290 bps). This decrease in Selling, general and administrative expenses was due to decreased advertising investment (20 bps) and lower overhead expenses (20 bps), as overhead efficiencies (60 bps) more than offset higher logistics costs (40 bps). This decrease in Other (income) expense, net was primarily due to gains from marketable securities and other assets, and a value-added tax refund.




39

(Dollars in Millions Except Per Share Amounts)
    Europe
 20222021% Change
Net sales$2,548 $2,841 (10.5)%
Operating profit$514 $682 (25)%
% of Net sales20.2 %24.0 %(380)bps

Net sales in Europe decreased 10.5% in 2022 to $2,548, as volume declines of 4.0% and negative foreign exchange of 10.5% were partially offset by net selling price increases of 4.0%. Organic sales in Europe in 2022 were even with 2021.

Organic sales in Europe in 2022 versus 2021 were flat as increases in Oral Care and Home Care organic sales were offset by a decrease in Personal Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories, partially offset by organic sales declines in the mouthwash category. The increase in Home Care was primarily due to organic sales growth in the fabric softener category, partially offset by organic sales declines in the hand dish category. The decrease in Personal Care was primarily due to organic sales declines in the skin care and liquid hand soap categories.

Operating profit in Europe decreased 25% in 2022 to $514, or 380 bps to 20.2% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (400 bps) as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (800 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (220 bps) and higher pricing.
40

(Dollars in Millions Except Per Share Amounts)
    Asia Pacific
 20222021% Change
Net sales$2,826 $2,867 (1.5)%
Operating profit$737 $844 (13)%
% of Net sales26.1 %29.4 %(330)bps

Net sales in Asia Pacific decreased 1.5% in 2022 to $2,826, driven by volume declines of 0.5% and negative foreign exchange of 6.5%, partially offset by net selling price increases of 5.5%. Organic sales in Asia Pacific increased 5.0% in 2022. Organic sales growth was led by the Greater China region, Australia and the Philippines.
The increase in organic sales in 2022 versus 2021 was primarily due to increases in Oral Care and Home Care organic sales. The increase in Oral Care was driven by organic sales growth in the toothpaste and manual toothbrush categories. The increase in Home Care was driven by organic sales growth in the fabric softener and hand dish categories.

Operating profit in Asia Pacific decreased 13% in 2022 to $737, or 330 bps to 26.1% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit (210 bps) and an increase in Selling, general and administrative expenses (120 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (770 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (310 bps) and higher pricing. This increase in Selling, general and administrative expenses was due to increased advertising investment (90 bps) and higher overhead expenses (30 bps), as higher logistics costs (90 bps) were partially offset by overhead efficiencies (60 bps).


    
41

(Dollars in Millions Except Per Share Amounts)
    Africa/Eurasia
 20222021% Change
Net sales$1,082 $1,045 3.5 %
Operating profit$228 $203 12 %
% of Net sales21.1 %19.4 %170 bps

Net sales in Africa/Eurasia increased 3.5% in 2022 to $1,082, as net selling price increases of 21.5% were partially offset by volume declines of 9.5% and negative foreign exchange of 8.5%. Organic sales in Africa/Eurasia increased 12.0% in 2022. Organic sales growth was led by Turkiye and South Africa.
The increase in organic sales in 2022 versus 2021 was primarily due to increases in Oral Care and Personal Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the bar soap category.
Operating profit in Africa/Eurasia increased 12% in 2022 to $228, or 170 bps to 21.1% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (210 bps) as a percentage of Net sales. This increase in Gross profit was primarily due to higher pricing and cost savings from the Company’s funding-the-growth initiatives (230 bps), partially offset by higher raw and packaging material costs (860 bps).
42

(Dollars in Millions Except Per Share Amounts)
    Hills Pet Nutrition
 20222021% Change
Net sales$3,713 $3,311 12.0 %
Operating profit$850 $901 (6)%
% of Net sales22.9 %27.2 %(430)bps

Net sales for Hill’s Pet Nutrition increased 12.0% in 2022 to $3,713, driven by volume growth of 4.0% and net selling price increases of 11.5%, partially offset by negative foreign exchange of 3.5%. The Company's previously disclosed acquisitions of pet food businesses contributed 2.5% to volume in Hill's. Organic sales in Hill’s Pet Nutrition increased 13.0% in 2022. Organic sales growth was led by the United States and Europe.

The increase in organic sales in 2022 versus 2021 was due to organic sales growth in the Science Diet and Prescription Diet categories.

Operating profit in Hill’s Pet Nutrition decreased 6% in 2022 to $850, or 430 bps to 22.9% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit (570 bps), partially offset by a decrease in Selling, general and administrative expenses (150 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (840 bps) and unfavorable mix due to private label sales resulting from the previously disclosed acquisitions of pet food businesses (120 bps), partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives (80 bps). This decrease in Selling, general and administrative expenses was primarily due to decreased advertising investment (160 bps).


43

(Dollars in Millions Except Per Share Amounts)
    Corporate
 20222021% Change
Operating profit (loss)$(1,305)$(1,064)23 %

Corporate operations include Corporate overhead costs, research and development costs, stock-based compensation expense related to stock options and restricted stock unit awards, restructuring and related implementation costs and gains and losses on sales of non-core product lines. The components of Operating profit (loss) for the Corporate segment are presented as follows:
20222021
Acquisition-related costs$(19)$— 
2022 Global Productivity Initiative(95)— 
Gain on the sale of land in Asia Pacific47 — 
Value-added tax matter in Brazil— 26 
Goodwill and intangible assets impairment charges(721)(571)
Corporate overhead costs and other, net(517)(519)
Total Corporate Operating profit (loss)$(1,305)$(1,064)




44

(Dollars in Millions Except Per Share Amounts)
Restructuring and Related Implementation Charges

On January 27, 2022, the Board approved the 2022 Global Productivity Initiative. The program is intended to reallocate resources towards the Company’s strategic priorities and faster growth businesses, drive efficiencies in the Company’s operations and streamline the Company’s supply chain to reduce structural costs.

Implementation of the 2022 Global Productivity Initiative, which is expected to be substantially completed by mid-year 2024, is estimated to result in cumulative pre-tax charges, once all phases are approved and implemented, in the range of $200 to $240 ($170 to $200 aftertax), which is currently estimated to be comprised of the following: employee-related costs, including severance, pension and other termination benefits (80%); asset-related costs, primarily accelerated depreciation and asset write-downs (10%); and other charges (10%), which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies. It is estimated that approximately 80% to 90% of the charges will result in cash expenditures. Annualized pre-tax savings are projected to be in the range of $90 to $110 ($70 to $85 aftertax), once all projects are approved and implemented.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (5%), Latin America (10%), Europe (45%), Asia Pacific (5%), Africa/Eurasia (10%), Hill’s Pet Nutrition (10%) and Corporate (15%).

For the twelve months ended December 31, 2022, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:
Twelve Months Ended December 31,
2022
Selling, general and administrative expenses
Other (income) expense, net90 
Non-service related postretirement costs15 
Total 2022 Global Productivity Initiative charges, pretax$110 
Total 2022 Global Productivity Initiative charges, aftertax$87 

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges incurred for the 2022 Global Productivity Initiative relate to initiatives undertaken by the following reportable operating segments:

Twelve Months Ended December 31,
 2022
North America11 %
Latin America 18 %
Europe 19 %
Asia Pacific%
Africa/Eurasia11 %
Hill's Pet Nutrition11 %
Corporate22 %
Total100 %



45

(Dollars in Millions Except Per Share Amounts)
The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:

Twelve Months Ended December 31,
 Employee-Related
Costs 
Incremental
Depreciation 
Asset
Impairments
OtherTotal
Balance at December 31, 2021$— $— $— $— $— 
Charges 102 — 110 
Cash Payments (53)— — (4)(57)
Charges against assets(15)— — — (15)
Foreign exchange(4)— — — (4)
Balance at December 31, 2022$30 $— $$$34 

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, written severance policies, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements of $15 for the twelve months ended December 31, 2022, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension liabilities.

46

(Dollars in Millions Except Per Share Amounts)
Non-GAAP Financial Measures

This Annual Report on Form 10-K discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Annual Report on Form 10-K. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding, the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the years ended December 31, 2022 and 2021 is provided below.

Selling, general and administrative expenses, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Interest (income) expense, net, effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Annual Report on Form 10-K both on a GAAP basis and excluding, as applicable, charges resulting from the 2022 Global Productivity Initiative, goodwill and intangible assets impairment charges, a gain on the sale of land in Asia Pacific, acquisition-related costs, a loss on the early extinguishment of debt and a benefit related to a value-added tax matter in Brazil. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the years ended December 31, 2022 and 2021 is presented within the applicable section of Results of Operations.

47

(Dollars in Millions Except Per Share Amounts)
The following tables provide a quantitative reconciliation of Net sales growth to organic sales growth for the years ended December 31, 2022 and 2021 versus the prior year:
Year ended December 31, 2022Net Sales Growth
(GAAP)
Foreign
Exchange
Impact
Acquisitions and Divestments
Impact
Organic
Sales Growth
(Non-GAAP)
Oral, Personal and Home Care    
North America3.5%—%—%3.5%
Latin America8.5%(2.0)%—%10.5%
Europe(10.5)%(10.5)%—%—%
Asia Pacific(1.5)%(6.5)%—%5.0%
Africa/Eurasia3.5%(8.5)%—%12.0%
Total Oral, Personal and Home Care1.0%(4.5)%—%5.5%
Pet Nutrition12.0%(3.5)%2.5%13.0%
Total Company3.0%(4.5)%0.5%7.0%
Year ended December 31, 2021Net Sales Growth
(GAAP)
Foreign
Exchange
Impact
Acquisitions and Divestments
Impact
Organic
Sales Growth
(Non-GAAP)
Oral, Personal and Home Care    
North America(1.0)%1.0%—%(2.0)%
Latin America7.0%(1.0)%—%8.0%
Europe3.5%4.0%—%(0.5)%
Asia Pacific6.0%3.0%—%3.0%
Africa/Eurasia6.5%(0.5)%—%7.0%
Total Oral, Personal and Home Care4.0%1.5%—%2.5%
Pet Nutrition15.0%1.5%—%13.5%
Total Company6.0%1.5%—%4.5%

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Annual Report on Form 10-K are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

48

(Dollars in Millions Except Per Share Amounts)
Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, share repurchases and acquisitions). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Cash Flow

Net cash provided by operations decreased to $2,556 in 2022 as compared to $3,325 in 2021, primarily due to changes in working capital and lower net income. The Company’s working capital as a percentage of Net sales was 1.0% in 2022 and (2.7)% in 2021. This change in working capital as a percentage of Net sales is primarily due to higher inventory (driven by higher raw and packaging material costs and increased levels to mitigate the risk of supply chain and logistics disruptions), higher accounts receivable, and lower accounts payable and accruals. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). 

Investing activities used $1,601 of cash in 2022 compared to $592 during 2021. Investing activities in 2022 included the Company’s acquisition of businesses from Red Collar Pet Foods and Nutriamo discussed in Note 3, Acquisitions to the Consolidated Financial Statements.

Capital expenditures in the year ended December 31, 2022 were $696, an increase from $567 in 2021. Capital expenditures increased in 2022 primarily due to capacity expansion of manufacturing facilities and sustainability projects. Capital expenditures for 2023 are expected to be approximately 4.0% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns.

Financing activities used $952 of cash during 2022 compared to $2,774 during 2021. The decrease in cash used was primarily due to an increase in the proceeds from debt issuances in 2022 to fund acquisitions as compared to 2021.

Long-term debt, including the current portion, increased to $8,755 as of December 31, 2022, as compared to $7,206 as of December 31, 2021, and total debt increased to $8,766 as of December 31, 2022 as compared to $7,245 as of December 31, 2021. The Company’s debt issuances and redemptions support the Company’s capital structure objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital.

During the third quarter of 2022, the Company issued $500 of three-year Senior Notes at a fixed coupon rate of 3.100%, $500 of five-year Senior Notes at a fixed coupon rate of 3.100% and $500 of ten-year Senior Notes at a fixed coupon rate of 3.250%. The debt issuances were under the Company’s shelf registration statement.

During the fourth quarter of 2021, the Company issued €500 of eight-year notes at a fixed coupon rate of 0.300% (the “Sustainability Bond”). The debt issuance was under the Company’s shelf registration statement. An amount equal to the net proceeds of the Sustainability Bond was allocated to finance or refinance, in part or in full, new and existing projects and programs with distinct environmental or social benefits pursuant to the Company’s Sustainable Financing Framework during the period from January 1, 2020 through July 31, 2022.

During the fourth quarter of 2021, the Company redeemed prior to maturity all of its outstanding 0.000% notes due 2021 with a principal amount of €500, originally issued on November 12, 2019. The redemption was financed with commercial paper borrowings. The redemption price was equal to the carrying amount of the debt extinguished.

In 1990, the Company’s Canadian subsidiary (“CP Canada”), issued C$145 of Canadian dollar-denominated unsecured unsubordinated 12.85% guaranteed notes due October 4, 2030 (the “Canada notes”). During the third quarter of 2021, CP Canada redeemed the Canada notes and recorded a loss on the early extinguishment of debt of $75, which is included in Interest (income) expense, net in the Consolidated Statements of Income, representing the difference between the redemption price and the carrying amount of the debt extinguished.

At December 31, 2022, the Company had access to unused domestic and foreign lines of credit of $3,401 (including under the facility discussed below) and could also issue long-term debt pursuant to an effective shelf registration statement.
49

(Dollars in Millions Except Per Share Amounts)
In November 2022, the Company entered into an amended and restated $3,000 five-year revolving credit facility with a syndicate of banks for a five-year term expiring November 2027, which replaced, on substantially similar terms, the Company's $3,000 revolving credit facility that was scheduled to expire in August 2026. Commitment fees related to the credit facility were not material.

Domestic and foreign commercial paper outstanding was $1,778 and $1,204 as of December 31, 2022 and December 31, 2021, respectively. The average daily balances outstanding of commercial paper in 2022 and 2021 were $1,858 and $2,052, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its available lines of credit (under the facilities discussed above).

The following is a summary of the Company’s commercial paper as of December 31, 2022 and 2021:
 20222021
 Weighted Average Interest RateMaturitiesOutstandingWeighted Average 
Interest Rate
MaturitiesOutstanding
Commercial Paper2.1 %20231,778 (0.4)%20221,204 
Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long-Term Debt and Credit Facilities to the Consolidated Financial Statements for further information about the Company’s long-term debt and credit facilities.

Dividend payments in 2022 were $1,691, an increase from $1,679 in 2021. Dividend payments increased to $1.86 per share in 2022 from $1.79 per share in 2021. In the first quarter of 2022, the Company increased the quarterly common stock dividend to $0.47 per share from $0.45 per share, effective in the second quarter of 2022.

The Company repurchases shares of its common stock in the open market and in private transactions to maintain its targeted capital structure and to fulfill certain requirements of its compensation and benefit plans. On March 10, 2022, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2022 Program”), which replaced a previously authorized share repurchase program (the “2018 Program”). The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

Aggregate share repurchases in 2022 consisted of approximately 13.4 million common shares under the 2022 Program, 3.4 million common shares under the 2018 Program and 0.3 million common shares to fulfill the requirements of compensation and benefit plans, for a total purchase price of $1,308. Aggregate repurchases in 2021 consisted of approximately 16.4 million common shares under the 2018 Program and 0.3 million common shares to fulfill the requirements of compensation and benefit plans, for a total purchase price of $1,320. Share repurchases net of proceeds from exercise of stock options were $890 and $896 in 2022 and 2021, respectively.

Cash and cash equivalents decreased $57 during 2022 to $775 at December 31, 2022, compared to $832 at December 31, 2021. Cash and cash equivalents held by the Company’s foreign subsidiaries was $735 and $784, respectively, at December 31, 2022 and 2021.







50

(Dollars in Millions Except Per Share Amounts)
The following represents the scheduled maturities of the Company’s contractual obligations as of December 31, 2022:
 Total20232024202520262027Thereafter
Long-term debt including current portion(1)
$6,977 $921 $510 $636 $538 $499 $3,873 
Net cash interest payments on long-term debt(2)
2,210 204 149 134 117 112 1,494 
Operating Leases586 124 88 69 54 50 201 
Purchase obligations(3)
723 476 139 50 37 18 
U.S. tax reform payments 185 46 62 77 — — — 
Total$10,681 $1,771 $948 $966 $746 $679 $5,571 
_______
(1)The Company classifies commercial paper and notes maturing within the next twelve months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. The amounts in this table exclude commercial paper.
(2)Includes the net interest payments on fixed and variable rate debt. Interest payments associated with floating rate instruments are based on management’s best estimate of projected interest rates for the remaining term of variable rate debt.
(3)The Company had outstanding contractual obligations with suppliers at the end of 2022 for the purchase of raw, packaging and other materials and services in the normal course of business. These purchase obligation amounts represent only those items which are based on agreements that are legally binding and that specify all significant terms including minimum quantity, price and term and do not represent total anticipated purchases.

Long-term liabilities associated with the Company’s postretirement plans are excluded from the table above due to the uncertainty of the timing of these cash disbursements. The amount and timing of cash funding related to these benefit plans will generally depend on local regulatory requirements, various economic assumptions (the most significant of which are detailed in “Critical Accounting Policies and Use of Estimates” below) and voluntary Company contributions. Based on current information, the Company is not required to make a mandatory contribution to its qualified U.S. pension plan in 2023. The Company does not expect to make any voluntary contributions to its U.S. postretirement plans in 2023. In addition, total benefit payments expected to be paid from the Company’s assets to participants in unfunded plans are estimated to be approximately $86 for the year ending December 31, 2023.

Additionally, liabilities for unrecognized income tax benefits are excluded from the table above as the Company is unable to reasonably predict the ultimate amount or timing of a settlement of such liabilities. See Note 11, Income Taxes to the Consolidated Financial Statements for more information.

As more fully described in Note 13, Commitments and Contingencies to the Consolidated Financial Statements, the Company has commitments and contingencies with respect to lawsuits, environmental matters, taxes and other matters arising in the ordinary course of business.
51

(Dollars in Millions Except Per Share Amounts)
Off-Balance Sheet Arrangements

The Company does not have off-balance sheet financing or unconsolidated special purpose entities.

Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies. The Company’s treasury and risk management policies prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose.

The sensitivity of our financial instruments to market fluctuations is discussed below. See Note 2, Summary of Significant Accounting Policies and Note 7, Fair Value Measurements and Financial Instruments to the Consolidated Financial Statements for further discussion of derivatives and hedging policies and fair value measurements.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost-containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements. See “Results of Operations” above for a discussion of the foreign exchange impact on Net sales in each operating segment.

The assets and liabilities of foreign subsidiaries are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.

The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its exposures relating to foreign currency purchases, assets and liabilities created in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates.

The Company’s foreign currency forward contracts that qualify for cash flow hedge accounting resulted in a net unrealized gain of $4 and $12 at December 31, 2022 and 2021, respectively. Changes in the fair value of cash flow hedges are recorded in Other comprehensive income (loss) and are reclassified into earnings in the same period or periods during which the underlying hedged transaction is recognized in earnings. At the end of 2022, an unfavorable 10% change in exchange rates would have resulted in a net unrealized loss of $80.

52

(Dollars in Millions Except Per Share Amounts)
Interest Rate Risk

The Company manages its mix of fixed and floating rate debt against its target with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates.

Based on year-end 2022 variable rate debt levels, a 1% increase in interest rates would have increased Interest (income) expense, net by $14 in 2022.

    The Company has completed its assessment of the impact of the discontinuation of LIBOR as a benchmark interest rate on its current financial instruments and contractual arrangements, including debt outstanding, and concluded it to be not material as the Company does not have significant exposure to LIBOR in either its debt or other financing arrangements. The Company will continue to monitor its exposure in subsequent periods.

Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as essential oils, resins, tropical oils, pulp, tallow, corn, poultry and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hills Pet Nutrition segment, to manage volatility related to anticipated raw material inventory purchases of certain traded commodities.

The Company’s open commodity derivative contracts that qualify for cash flow hedge accounting resulted in a net unrealized gain of $1 an